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NONCONTACT THREE-DIMENSIONAL 
DIFFUSE OPTICAL IMAGING OF DEEP 
TISSUE BLOOD FLOW DISTRIBUTION 
RELATED APPLICATIONS 
This application claims priority to U.S. Provisional Appli­
cation 62/136,707, filed Mar. 23, 2015, which is hereby 
incorporated by reference in its entirety. 
GOVERNMENT SUPPORT 
This invention was made with govermnent support under 
grants R21-AR062356 and UL-1RR033173 Pilot Grant 
awarded by the National Institutes of Health. The govern­
ment may have certain rights in the invention. 
FIELD OF THE INVENTION 
10 
2 
light or radiation. Bums can cause swelling, blistering, 
scarring and, in serious cases, shock and even death. They 
also can lead to infections because they damage skin's 
protective barrier. Treatment for bums depends on the cause 
of the bum, how deep it is, and how much of the body it 
covers. Antibiotic creams can prevent or treat infections. For 
more serious burns, treatment may be needed to clean the 
wound, replace the skin, and make sure the patient has 
enough fluids, nutrition, blood flow, and tissue oxygen. 
As a further example, mastectomy skin flap necrosis may 
ultimately lead to implant exposure, infection and implant 
loss. In some of these cases, the complications may be so 
devastating as to cause a failure of reconstruction4•5 •6. Of the 
75,000 expander-implant based reconstructions performed 
15 in 2013, more than 18,000 resulted in implant loss, second­
ary to complications 7. The cost of implant loss alone is 
>$30,0008, plus the fees incurred by additional operating 
room time, clinic visits, inpatient stays, surgeon costs and 
procedure fees. 
The present invention relates to the application of diffuse 20 
correlation tomography (DCT) through both noncontact 
(ncDCT) and charge-coupled-device (CCD)-based noncon­
tact speckle contrast (nc_scDCT) approaches for three­
dimensional (3-D) reflectance imaging of deep tissue (up to 
Similarly, head and neck cancer accounts for 3 to 5% of 
all cancers in the United States9. Despite all the advances in 
non-surgical treatments, surgery remains an important tool 
in the management of these cancers. Primary or salvage 
surgeries are extensive and often lead to major head and 
1.5 cm depth) to better assess any potential tissue injury 
therein. 
BACKGROUND 
The ability to image within diseased or sensitive tissue is 
highly desirable as it provides further information as to the 
underlying health of the tissue, but remains problematic in 
successful execution due to accessing the tissue without 
touching the surface. Significant problems with contact 
measurements (using a probe in contact with tissue) include 
the risk for infection of vulnerable tissues ( e.g., wounds, 
bums, reconstructive tissue flaps) and the deformation of 
soft tissues (e.g., breasts) distorting blood flow and oxygen-
ation. 
25 neck defects that require complex reconstructions with local 
flaps, regional flaps, or free tissue transfer flaps. Intraopera­
tive decreases in blood flow after flap anastomosis have been 
observed10•11, which may lead to failure of flap thrombosis. 
Thus, knowledge of tissue blood flow changes after tissue 
30 transfer may enable surgeons to predict the failure of flap 
thrombosis at an early stage to salvage ischemic flaps. 
Current imaging diagnostic tools include x-ray computed 
tomography (CT), magnetic resonance imaging (MRI), posi­
tron emission tomography (PET) and ultrasonography, but 
35 most of these imaging methods are prohibitively expensive 
and generally only provide tissue morphological informa­
tion. Moreover, some of these techniques (e.g., CT and PET) 
expose patients to ionizing radiation12•13. Doppler ultra-
Chronic wounds affect over 5 million Americans each 40 
sound is limited in measuring only blood flow in large 
vessels. 
year, resulting in over $20 billion in health care costs. 
Individuals with disabilities and diabetes as well as the 
elderly have the highest risk of developing chronic wounds. 
Patients afflicted with chronic wounds suffer from physical 
pain and disabilities in addition to psychological and emo­
tional stresses and poor quality of life. Current treatments for 
chronic wounds include cleansing, debridement, maintain­
ing a moist tissue environment, and when possible, elimi­
nating the underlying pathology or factors that contributed 
to poor wound healing. In advanced cases, amputation may 
become necessary. Death, especially in elderly patients, may 
result from sepsis that can be associated with chronic 
wounds. Multiple factors can lead to impaired wound heal­
ing. Local factors that influence healing include tissue blood 
flow and oxygenation. Pressure ulceration, For example, 
occurs when the skin and underlying tissues are compressed 
for a period of time between the bone and the surface on 
which the patient is sitting or lying. Constant pressure 
against the tissue reduces blood supply to that area which 
results in tissue ischemia1• 2. Ultrasound imaging results 
have recently shown that early pressure ulcers originate 
from deep tissues attached to the bone and spread upwards, 
eventually to the skin3. Therefore, quantification of blood 
flow in deep wound tissues is crucial for accurate diagnosis 
and treatment monitoring. 
As another example of tissue injury, a burn is damage to 
body's tissues caused by heat, chemicals, electricity, sun-
Often, the surface of a tissue does not provide sufficient 
feedback as to the health of the tissue within. For example, 
when flap ischemia is a concern, most surgeons rely primar­
ily on careful and frequent visual examination of the flap 
45 surface. Several tools and techniques are currently in use to 
monitor flaps in order to detect changes in viability in a time 
frame that allows for salvage of the flap from its nonviable 
state. While transcutaneous or implantable ultrasound Dop­
pler technologies are commonly used to assess blood flow 
50 through large axial vessels, peripheral flap blood flow 
remains largely subjective in its clinical assessment11 •27-29. 
Laser Doppler technique has also been used to monitor 
blood flow at a tiny spot of superficial tissue, which may not 
reflect precisely hemodynamic changes in the bulk flap 
55 tissue10•30•31. The ischemia and hypo-perfusion that can 
occur intra-operatively in the flap are often not evident to the 
surgeons until days/weeks later when it presents as skin flap 
necrosis. Therefore, clinical assessment alone is not reliable. 
For example, mastectomy skin flap necrosis, infection and 
60 implant loss are all interlinked by a shortfall of perfusion and 
tissue oxygen at the microcirculatory level. Previously, a 
prospective clinical trial of tissue expander-implant breast 
reconstruction has been conducted with intraoperative 
evaluation of mastectomy skin flaps by clinical assessment, 
65 laser-assisted indocyanine green dye angiography, and fluo­
rescein dye angiography32. Due to the requirement of an 
intravenous injection, these methods lack feasibility for 
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continuous use in clinical preoperative and postoperative 
settings; and they are time-dependent, requiring evaluation 
after a particular time period following dye injection. Thus, 
noninvasive, continuous, and quantitative imaging methods 
are highly advantageous to assess tissue hemodynamic states 5 
and alterations for perioperative management flap ischemia 
to reduce the likelihood of postoperative ischemic compli­
cations. 
4 
(2-D) array of photodiodes. In yet further parts, the detector 
array may comprise a 2-D array detectors provided by a 
charge-coupled-device (CCD). In instances where the detec-
tor array is linear, coupling the imaging probe to a motorized 
stage allows the probe to be systematically and automati­
cally moved across a region of interest of the tissue. 
In aspects where the detector array comprises a 2-D CCD, 
the NIR light can be applied through at least four source 
fibers to borders of a region of interest of a tissue of a subject 
10 with the CCD detecting near-infrared diffused light through 
an optical lens coupled to a CCD. Contact with the subject 
can be avoided by either connecting the source fibers with 
optical lenses or by applying the light through a Galva 
m!fror. 
Near-infrared (NIR: 650 nm to 900 nm) diffuse optical 
technologies provide a noninvasive and relatively inexpen­
sive tool for functional imaging of tissue hemodynamics in 
deep microvasculature up to several centimeters14-17. The
most commonly used NIR diffuse optical spectroscopy/ 
tomography (DOS/DOT) can currently quantify tissue 
hemoglobin concentration and blood oxygen saturation. 15 
Traditional DOS/DOT using the fiber-optic interface has 
been used over several decades to detect distribution of 
oxygenation alternations in tissues18-22.
A relatively new NIR diffuse correlation spectroscopy 
(DCS) technique has been also developed for direct mea- 20 
surement of blood flow in deep tissues (up to -1.5 cm)2 3•24.
DCS employs coherent NIR light to probe deep tissues and 
single-photon-counting avalanche photodiodes (APDs) to 
detect temporal speckle fluctuations of the diffuse light on 
tissue boundaries. Long-coherence lasers and APD detectors 25 
are connected with optical fibers placed on the tissue bound­
ary for DCS measurements. The measured temporal speckle 
fluctuation depends on the motion of moving scatterers 
(primarily red blood cells in the microvasculature ), which is 
related to a blood flow index (BFI). BFI can be quantified by 30 
iteratively fitting the measured light intensity autocorrela­
tion function. 
Despite advances in DCS technologies, there have been 
limited imaging applications of diffuse correlation tomog­
raphy (DCT). A probe-tissue contact based DCS/DCT 35 
approach has been described, but as with other approaches 
it remains disadvantaged in vivo due in part to compression­
induced hemodynamic alterations or potential infections on 
ulcerous tissues. Another limitation lies in their reliance on 
analytical solutions that assumed a simple semi-infinite flat 40 
tissue geometry. Thus, an approach without the request of 
contact measurement may address these limitations. 
SUMMARY OF THE INVENTION 
The present invention also provides in part for computing 
systems to construct a 3-D flow image from collected data. 
The computing systems may execute a finite-element­
method (FEM) based facilitation of detected unnormalized 
electric field autocorrelation function, Gi(r;t)=( E(r, t)E*(r, 
t+i:)), by applying the data set to an adapted correlation 
diffusion equation of V·((D�f)/';)VGi (r;t))-(µa(r)+1hµ)(r)
k/a ( llr2(t)) )G 1 (r;t)=-S(r)e' =d.) where r is the position 
vector and v is the light speed in the medium. µa(r) is the
medium absorption coefficient, and D(r)ssv/3µ',(r) is the
medium photon diffusion coefficient, µ)(r) is the medium
reduced scattering coefficient, -i: is autocorrelation delay
time, c is speed of light in vacuum, and A is wavelength and
(r,)=1/3µ)(r)k0
2a( llr(-i:)) as a dynamic absorption with k0 as
the wave number of an incident light field, a is the unitless
ratio of dynamic scatterers to total ( dynamic and static)
scatterers. ( llr2(-i:)) is the mean-square displacement in time
-i: of the moving scattering particles (e.g., red blood cells);
for the case of diffuse motion, ( llr(-i:)) =6DB(r)-i: where DB 
(r) (unit: cm2/s) is an effective diffusion coefficient of the
moving scatterers; and then redefining µad(r,-i:)=2µ)(r)
k/aDB(r)-i: then extracting aDB(r) as blood flow index that
can collectively be compiled with multiple blood flow
indices measured at difference source-detector (S-D) pairs to
construct an image. In instances where an obtained data set
may comprise a measured spatial speckled contrast K (such
as by a CCD), these data may be first converted to a blood
flow index across each of S-D pair prior to extracting
aDB(r). Such can be accomplished by relating K to the
normalized temporal autocorrelation function g1 by K
2=2�/
45 Tf0 r(l--i:/T)[g1 (r,-i:)]
2d-i:,
where � relates detector and speckle size. This is then
followed by identifying a nonlinear relationship by K2=f
(aDB,T,µa,µ),A,�,S-D,k0),
The present invention provides systems and methods for 
three-dimensional (3-D) reflectance imaging of blood flow 
distribution in deep tissue. The systems offer an approach 
that avoids contact with the subject being imaged, thereby 
offering systems that allow for imaging of sensitive, supple 
and, finally minimizing (K2-f)2 to obtain the blood flow
50 index. 
The present invention also provides in part for creating a 
3D solid model of the tissue being imaged by first acquiring 
autocorrelation functions at each measurement location of 
the S-D array; and then acquiring a surface geometry of the 
55 tissue with a 3-D camera that includes the boundaries of the 
or diseased tissue. The imaging can be achieved of depths of 
1.5 cm or less. The systems and methods provide for 
projecting and focusing an imaging probe on to a tissue 
surface of a subject. The imaging probe may comprise 
source fibers connected to long-coherence lasers that emit 
near-infrared (NIR) light. The systems and methods further 
comprise a detector array also projected and focused on the 
tissue. The imaging probe may then apply beams of NIR 
light through a set of optical lenses to the tissue and the 
detector array to detect the diffused NIR light from the tissue 60 
through a second set of optical lenses. An image may then 
be constructed based on measured diffused near-infrared 
light transporting from the source fibers through the tissue to 
the detector array. 
The systems and methods provide in part for the detector 65 
array to be at least one linear array of photodiodes. In other 
parts, the detector array may comprise a two-dimensional 
region of interest. Following such, a solid tissue model may 
be created with arbitrary surface from the captured surface 
image with a 3-D CAD enabled alignment system. On the 
tissue model, the sources and detectors from the S-D array 
on the model can then be aligned which allows for 3-D 
reconstruction of blood flow index distribution from auto­
correlation function measurements. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows (a) the custom-made noncontact diffuse 
correlation spectroscopy (ncDCS) system including (1) a 
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noncontact optical probe, (2) a linear motorized stage, (3) a 
multiple-axis stand holder, (4) a laptop control panel, and (5) 
a ncDCS device and (b) the front view of ncDCS device. 
FIG. 2 shows (a) the mechanical configuration and (b) 
optical paths of ncDCS probe. The source and detector fibers 5 
are innovatively projected through separated lens paths onto 
the tissue surface, which avoids cross-talk between light 
delivery and detection. 
FIG. 3 shows schematic diagram of a noncontact diffuse 
correlation tomography (ncDCT) with rotational scanning 10 
system. (a) A motorized rotational stage was used to 
remotely scan over a representative region of interest (ROI) 
on a breast. A laser pointer was used to align the rotation axis 
approximately through the nipple. The relative position 15
between the ncDCT probe and ROI (i.e., working distance, 
initial step of scanning) can be adjusted manually by the 
linear stage and the rotational platform. (b) Fifteen single­
mode detector fibers connected with A PDs were equally 
arranged in a 7 mm line to cover a 20 mm range through the 20 
magnification of lenses. (c) The source and detector fibers 
were projected on the breast surface using achromatic 
lenses. Two source paths projecting two coherent NIR lasers 
(785 nm) were attached to the sides of the detector path. 
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FIG. 11 shows the rBF data measured by ncDCS from all 
flap cases ( cases 1 to 8) including the unsuccessful one ( case 
8) highlighted with large hexagrams. Note that data from the 
unsuccessful case ( case 8) at day 7 are not available due to 
the subsequent re-flap before that day. The error bars (see
FIG. 13) for individual cases are not shown for clarity
FIG. 12 shows the comparison of rBF changes measured 
by ncDCS between the successful and unsuccessful flaps. 
Averaged rBF values over the seven successful cases during 
operation and on postoperative days 2, 4, 7 are presented as 
mean standard errors ( error bars represent the variations 
over seven cases). rBF from the unsuccessful flap ( case 8) 
was measured at the time of flap elevation and on postop­
erative days 2 and 4. 
FIG. 13 shows results of computer simulations and phan­
tom experiments measured by ncDCT on a homogeneous 
slab background and internally placed tube-shaped anomaly 
of varied flow contrast. The reconstructed anomaly from the 
last step with highest flow contrast is shown (a) 3-D overlaid 
on the assigned anomaly and two-dimensional (2-D) cross­
section views (x, y, z) in the simulation and (c) in the 
phantom experiment. Both (b) and ( d) show a linear rela­
tionship between the assigned anomaly and reconstructed 
flow indices expressed as ratios of relative changes respec­
tively in the simulation and phantom experiment. 
FIG. 14 shows a 3-D camera to obtain surface images of 
the breast and reference plane (RP) for ncDCT image 
reconstruction. (a) The breast surface with source marks was 
imaged by the 3-D camera. An "imaging region" C-5"x5"), 
FIG. 4 shows an illustration of (a) the ncDCT focusing 25 
apparatus with photon projections to and from a sample, (b) 
linear array of single-mode detector fibers, (c) motorized 
linear scanning staging over a representative ROI, and (d) 
the pump-connected cylindrical tube-shaped anomaly in a 
tank filled with Intralipid liquid solution. 
FIG. 5 shows the setup for testing a charge-coupled 
device (CCD)-based speckle contrast diffuse correlation 
tomography (scDCT) system for 3-D flow imaging. (a) The 
CCD is focused onto a liquid phantom surface. A square 
metal holder positioned four fibers supporting their ferrule 35 
tips on the liquid surface. The holder provided a 2.4 cmx2.4 
cm open area. The optical switch distributed laser light into 
the four source fibers sequentially. (b) Configuration of the 
four sources, CCD field of view (FOY), solid phantom 
placement, and detector area. 
30 displayed in the inset, was selected inside the FOY for 
generating the solid breast model (see FIG. 32). (b) After the 
mannequin was removed, a small foam pad was attached to 
the ncDCT scanner. The 3-D camera took another image to 
FIG. 6 shows a CCD-based fully noncontact scDCT 
(nc_scDCT) system using separated sources (a) or Gavano 
mirror (b) based sources for imaging of flow contrast. ( c) A 
typical source-detector distribution pattern. 
include the small foam pad whose surface (RP) was adjusted 
perpendicularly to the rotation axis. The RP was used for the 
coregistration of two coordinate systems: 3-D camera and 
ncDCT. 
FIG. 15 shows procedures converting the acquired breast 
surface to a solid breast model for ncDCT image reconstruc-
40 tion. (a) The mannequin breast surface with source marks 
and the reference plane (RP) were integrated into one image. 
The three pairs of source marks and the rotation center mark 
can be clearly seen. (b) A bottom plane (BP) parallel to the 
RP was created and a 3-D solid breast model was then 
FIG. 7 shows the protocol for perioperative blood flow 45 
monitoring during free tissue transfer measured by ncDCS: 
generated by extruding the 2-D contour on BP along the 
rotation axis to the 3D breast surface. 
(a) intraoperative measurement on the elevated flap; (b) 
intraoperative measurement on the flap after anastomosis 
through mouth cavity; ( c) postoperative measurement on the 
transferred flap. 
FIG. 8 shows the flow variations at the four different S-D 
separations (10.0, 15.7, 22.8, 30.0 mm) measured by ncDCS 
on the (a)-(d) liquid phantom and (e)-(h) healthy forearm 
over seven days. The error bars represent the standard 
deviations over the 2-min measurements. 
FIG. 9 shows the blood flow variations (rBF) measured by 
ncDCS at (a)-(d) four S-D separations in one successful case 
(case 1) and (e)-(h) the unsuccessful case during the opera­
tion and at postoperative days 2, 4, 7 ( data are not available 
FIG. 16 shows coregistration procedures to place the solid 
breast model obtained in 3-D camera coordinate system 
(left) into the ncDCT coordinate system (right). The rotation 
50 center of the ncDCT probe obtained by the 3-D camera (left) 
was placed at (0, 0, 50 mm) in the ncDCT coordinate system 
(right). 
FIG. 17 shows alignment of sources and detectors of 
ncDCT on the surface of the solid breast model. (a) A 
55 scanning plane (SP) perpendicular to the BP and crossing the 
optical rays of sources and detectors was first aligned to pass 
through the initial pair of source marks (Ml and M2). (b) 
Each source or detector path was then simplified as a single 
at postoperative day 7 for the unsuccessful case). "E" 60 
represents the time point when the flap is raised. Day "O" 
represents -30 min after flap anastomosis, which is used as 
the baseline for normalization. Error bars represent standard 
deviations over the 2-min time course data. 
chief optical ray perpendicular to the straight line connecting 
the source marks (Ml to M2). The sources and detectors 
along the chief optical rays were then projected onto the 
surface of the solid breast model. The SP was next rotated 
around the rotation axis step-by-step with a 3-deg increment 
per step for projecting sources and detectors at all scanning 
steps. FIG. 10 shows Averaged rBF data measured by ncDCS at 65 
four S-D separations in all successful cases over seven days. 
Error bars represent standard errors over subjects. 
FIG. 18 shows characterization of source aligrnnent errors 
at different scanning steps of ncDCT. (a) The projected 
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source close to M6 is used for demonstration. Line 1 and 
Line 2 are perpendicular projections of M6-M2 and M6-M5 
on the BP, respectively. The lengths of Line 1 and Line 2 are 
defined as I,an and Irad, respectively. Plane 1 crosses MS and 
M6 while Plane 2 crosses M6 and is perpendicular to Plane 
8 
relationships between the assigned and reconstructed peak 
and average BFI contrasts at different depths. 
FIG. 25 shows noise influence on imaging accuracy of 
ncDCT. An anomaly was placed beneath the surface of the 
breast-shaped mesh with varied central depths from 7 to 15 
mm. (a) and (b) show the center location and deviation of the
anomaly at different depths, reconstructed with or without
noise. ( c) and ( d) show percentage deviations of anomaly
peak and average BFI contrasts at different depths, recon-
1. Both Plane 1 and Plane 2 are perpendicular to the BP. (b)
a,an and arad are the distances between the aligned and
marked source points along tangential and radial directions,
respectively, which can be measured by the distances from
the aligned source point to the Plane 1 and Plane 2, respec­
tively
10 structed with or without noise. 
FIG. 19 shows ncDCT modeling procedures and results of 
solid breast meshes with the sources and detectors aligned 
on the mannequin (upper panel) and human (bottom panel) 
breasts. The images of mannequin (a) and human (d) breast 15 
surfaces and corresponding reference planes were obtained 
by the 3-D camera. The 3-D solid breast models were 
generated by extruding the 2-D circular contours on BP 
along the rotation axis to the breast surfaces. The breast 
volume meshes [(b) and (e)] were then created from the 3-D 20 
solid breast models. Finally, the sources and detectors were 
aligned on the surfaces of solid volume meshes [(c) and (f)]. 
FIG. 20 shows ncDCT image reconstruction results from 
computer simulations (upper panel) and the human breast 
(bottom panel). (a) A breast mesh with an assigned sphere 25 
anomaly (radius=5 mm) at the center of the ROI and 8 mm 
beneath the surface of the mannequin breast. The red and 
blue dots represent the sources without and with alignment 
errors, respectively. The detectors are not shown for clarity. 
(b) Reconstructed anomaly using the sources and detectors 30 
without alignment errors. ( c) Reconstructed anomaly using 
the sources and detectors with assigned alignment errors. ( d) 
Ultrasound image of breast tumor (inside the dashed circle 
area) in the human subject. (e) Reconstructed human breast 
tumor using the solid breast mesh with the sources and 35 
detectors aligned on the human breast. (f) Comparison of 
tumor locations determined by ncDCT and ultrasound imag­
ing on x-y plane: (1) the reconstructed tumor is projected on 
the breast surface, (2) the central location of the tumor 
determined by the ultrasound probe, and (3) source marks of 40 
ncDCT scanning. 
FIG. 21 shows a flowchart outlining the sequence and 
commands used in the modified NIRFAST to generate a 
forward model for ncDCT image reconstruction. 
FIG. 22 shows a flowchart outlining the sequence and 45 
commands used in the modified NIRFAST to solve diffuse 
correlation tomography inverse problem for ncDCT image 
reconstruction. 
FIG. 26 shows comparison of anomaly reconstructions 
without and with a priori structural information for ncDCT. 
The top [(a)-(e)] and bottom [(f)-(j)] panels show the recon­
structed flow contrast distributions of an anomaly ( assigned 
a 10-fold flow contrast) located at 7 and 15 mm central 
depths, respectively. (a) and (f) show reconstructed results 
without the a priori structural knowledge of the anomaly; (b) 
and (g) show the reconstructed results with the a priori 
structural knowledge; (c) and (h) show the reconstructed 
results without the a priori structural knowledge and with 
noise. ( d) and (i) show the reconstructed results with the a 
priori knowledge information and with noise. The flow 
contrast profiles crossing the yellow lines are shown in ( e) 
and (j). 
FIG. 27 shows clinical examples of two low-grade car­
cinomas in situ using ncDCT. (a) Patient 1 (Pl) ultrasound 
image taken from radio direction shows a 10.2x6.65 mm2 
oval mass (inside the yellow dashed circle) with circum­
scribed margins parallel to the skin. The mass center is 
located at 19.2 mm beneath the skin surface. A core biopsy 
revealed a ductal papilloma with low-grade ductal adeno-
carcinoma in situ. ( d) Patient 2 (P2) ultrasound image shows 
an 8.5x3.5 mm2 mass (inside the yellow dashed circle),
located at 13.3 mm beneath the skin surface. A core biopsy 
revealed atypical ductal hyperplasia and low-grade carci­
noma in situ. (b) and ( e) show the reconstructed 3-D tumor 
blood flow contrasts with FWHM thresholds for Pl and P2, 
respectively. The backgrounds are presented with 30% trans­
parency of the original color clarity. For the comparison of 
ultrasound and ncDCT results, an ultrasound imaging plane 
along the transducer line and across the overlapped two 
specific sources (Sl and S2) is presented in the 3-D recon­
structed image. (c) and (f) show the cross-section views of 
tumor flow contrast images through the ultrasound imaging 
planes, which can be directly compared to the 2-D ultra­
sound tumor images [(a) and (d)], respectively. 
FIG. 28 shows results measured by scDCT. (a) Original 
intensity pattern for source S2 on the homogeneous phantom 
using scDCT. (b) Desmeared intensity distribution of (a) FIG. 23 shows recovery of anomaly blood flow contrasts 
inside the slab-shaped and breast-shaped volume meshes for 
ncDCT image reconstruction. A sphere anomaly with a 
diameter of 10 mm and 10-fold flow contrast was placed at 
7 mm beneath the surface of background tissue volumes. (a) 
and ( e) show the original assigned anomalies inside the 
volume meshes with sources and detectors aligned on the 
mesh surfaces; (b) and (f) show the reconstructed anomalies 
with full-width at half-maximum (FWHM) thresholds; (c) 
and (g) show 2-D cross-section views of original flow 
contrast distributions through the anomaly centers; ( d) and 
50 with a corresponding S-D separation axis. These images 
depict contours of the intensity profiles with dots represent­
ing 21 effective detectors for demonstrating the K distribu­
tion with the S-D separations. Note that the dots are not to 
scale and the smaller dots serve as an ellipsis for the 
55 intermediate detectors. 
(h) show the 2-D cross-section views of reconstructed flow 60 
contrast distributions.
FIG. 24 shows evaluation of reconstruction accuracy of 
ncDCT in the breast-shaped volume mesh. (a) and (b) show 
the center location and deviation of the reconstructed 
anomaly at different depths; (c) shows the percentage devia- 65 
tions of anomaly peak and average blood flow index (BFI) 
contrasts at different depths; (d) and (e) show the linear 
FIG. 29 shows results measured by scDCT. (a) K for all 
sources from detectors defined along the center row with and 
without smear correction (SC) and numerically simulated K 
at the S-D separations. (b) DB for center row detectors. 
FIG. 30 shows results speckle contrast distributions from 
Sl on homogeneous and heterogeneous phantoms, measured 
by scDCT. 
FIG. 31 shows reconstructed 3D flow contrasts measured 
by scDCT. Three-dimensional overlaid cross sectional views 
of the slab phantom (a) without heterogeneity and (b) with 
heterogeneity. (c) Two-dimensional cross-sectional view (x 
and y through side centers; z at 24.5) of the region with 
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mentation cost and dimension. With a linear array of APDs 
in the ncDCT, coverage of the ROI is achieved by mechani­
cally scanning the probe over the ROI for complete cover­
age, which can take tens of minutes. By contrast, the 
heterogeneity as extracted by half max contrast threshold 
criteria. The true region with heterogeneity is depicted by 
centered squares. (d) The extracted (half max contrast 
threshold) region with heterogeneity obtained by computer 
simulation. Images displayed with ParaView (Kitware, 
N.Y.).
FIG. 32 shows phantom test results measured by the
nc_scDCT. (a) The point laser source (785 nm) and CCD 
were focused onto a homogenous liquid phantom surface. 
(b) Configuration of the point source and 3 7 detectors on the
CCD inside the FOY (c) Comparison of flow indices mea­
sured at multiple detectors with or without polarizers cross­
ing the source and detectors.
5 nc_scDCT approach uses a CCD to detect spatial diffuse 
speckle contrasts for blood flow measurement. Hundreds of 
detectors provided by a CCD unit omit the probe scanning 
phase and significantly improve the spatial and temporal 
resolution. Further, the CCD detection used in the 
FIG. 33 shows in vivo test results in a human forearm 
measured by the nc_scDCT. (a) The point laser source (785 
nm) and CCD were focused onto the surface of forearm. (b) 
Blood flow responses in forearm during 4-minute arterial 
cuff occlusion measured by the nc_scDCT with source­
detector (S-D) separations of 3, 6, 10, and 14 mm. 
10 nc_scDCT allows for higher temporal (a few seconds) and 
spatial resolution (1 to 2 mm) as well as lower cost and 
smaller dimension of the instrument, compared to the APDs 
used in the ncDCT. Further still, single-photon-counting 
APDs used in ncDCT are more sensitive (but more expen-
15 sive) than the CCD detection. Both systems are discussed 
independently below. 
With the systems described herein, the present invention 
further provides, in part, for detecting and imaging blood 
flow within a deep tissue. Through the type of detector 
FIG. 34 shows results using nc_scDCT probe (a) on a 
homogeneous slab phantom background with internally 
placed tube-shaped anomaly of varied flow contrast (b ). 
DETAILED DESCRIPTION 
20 utilized ( e.g., via APDs or CCD), tissue can be imaged from 
the surface to approximately 1.5 cm depth within the tissue. 
The tissue can be any tissue that is exposed such that NIR 
light may be applied, such as a naturally exposed tissue, e.g., 
skin or during a surgical procedure or through the opening 
25 of a generated surgical flap. 
The present invention similarly provides methods for 
assessing and monitoring a tissue. Those skilled in the art 
will appreciate that the systems described herein can obtain 
an image at any time that an image is desired. For example, 
30 using the systems described herein, an image may be 
obtained before, during and after surgical procedures to 
determine the success of a procedure, to obtain a diagnosis, 
or to review or follow a course of treatment. Those skilled 
The present invention concerns improvements in the 
fields of diffuse correlation spectroscopy (DCS) and diffuse 
correlation tomography (DCT). The present invention 
described herein provides for noncontact DCS (ncDCS), 
noncontact DCT (ncDCT), speckled contrast DCT (scDCT) 
and noncontact speckle contrast DCT (nc_scDCT) systems 
and methods of using such for deep tissue flow measure­
ments without probe-tissue contact, as well as novel 
approaches to creating a reconstructed 3-D image of blood 
flow distributions from data collected by these systems 35 
through a modification to the finite-element-method (FEM)­
based 3-D image reconstruction (originally designed for 
DOT). The FEM-based image reconstruction allows for the 
recovery of blood flow distributions in deep tissues with 
arbitrary geometries. Both of these physical systems incor- 40 
porate core DCS/DCT technology as set forth U.S. Pat. No. 
8,082,015 (which is hereby incorporated by reference in its 
entirety). Briefly DCS/DCT employs coherent near infrared 
(NIR) light to probe deep tissues and single-photon-counting 
avalanche photodiodes (APDs) to detect temporal speckle 45 
fluctuations of the diffuse light on tissue boundaries. Long­
coherence lasers and APD detectors are connected with 
optical fibers placed on the tissue boundary for contact 
DCS/DCT measurements. The measured temporal speckle 
fluctuation depends on the motion of moving red blood cells 
in the art will appreciate that the only limitation to obtaining 
an image of a tissue is access to the tissue such that the 
system can provide the requisite light. 
The present invention further provides systems that can 
measure or assess multiple parameters within a tissue. As 
described herein, application of NIR light allows for the 
detection and assessment of blood flow with a tissue. High­
resolution imaging with multiple functional outputs has the 
potential to guide the creation of more refined treatment 
strategies that incorporate knowledge of heterogeneities to 
yield higher intervention efficacy. NIR diffuse optical/fluo­
rescence tomography (DOT/DFT) has gained great interest 
as a fast, portable, and inexpensive technology for functional 
blood oxygenation tomography (DOT) or fluorescence con­
centration tomography (DFT). Through utilizing multiple 
optical sources and fiber optical switches connected to NIR 
in the microvasculature (i.e. blood flow). By contrast, diffuse 
speckled contrast imaging utilizes a charge-coupled-device 
(CCD) to detect spatial speckle contrasts of the diffuse light
throughout the tissue.
50 lasers at different wavelengths (e.g., 785 nm and 830 nm), 
other parameters such as tissue blood oxygenation or fluo­
rescence (with optical filters) can also be detected. Thus, 
through incorporating these other imaging methodologies 
within the systems described herein, a hybrid DOT/DFT/ 
55 DCT system with nc or sc feature is achieved. Such other 
detected parameters may then be independently imaged or 
overlaid with one or more measured parameters (see, e.g. He 
et al., J. Biomed. Optics. 18: 037001 (2013) and Shang et al., 
Both ncDCT and nc_scDCT systems deliver and detect 
NIR light through optical lenses to the surface of a tissue, 
thereby removing the previously required need to be in 
contact with the tissue. The ncDCT, which features ava­
lanche photodiode (APD) detection, and the nc_scDCT 
process, which features CCD detection, are distinguished by 60 
the transition from temporal to spatial diffuse speckle inten­
sity fluctuations. NIR light ranging from 650 to 900 nm is 
generated by a coherent laser with the power of -100 mw. 
The ncDCT approach uses a limited number of expensive 
but highly sensitive APDs to detect temporal diffuse speckle 65 
fluctuations for blood flow measurement, which limits the 
system's spatial-temporal resolution and increases instru-
Optics Lett. 34: 3556-3558 (2009)). 
Hardware Advancements 
All systems discussed improve on limitations in applica­
tion of the DCS/DCT technology (U.S. Pat. No. 8,082,015, 
which is hereby incorporated by reference in its entirety). 
Presented herein are several advancements in the apparatus 
required for successfully obtaining a desired 3-D image of 
blood flow distribution in deep tissue noninvasively. The 
advancements feature the development of noncontact (nc) 
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systems for APD-based DCT and the development ofCCD­
based DCT (i.e., speckled contrast (sc) DCT). As discussed 
herein, these advancements can be integrated to a DCS/DCT 
system in several ways. 
The present invention therefore provides, in part, for 5 
systems and methods of using such that are capable of 
producing a DCT image without contacting the tissue being 
imaged. As shown in FIGS. 1 and 2, a DCS system that 
avoids contact with a tissue (the ncDCS apparatus depicted) 
is a simple spectroscopic version of a DCT system (as 10 
described herein) with limited numbers of sources and 
detectors. 
FIGS. 3 and 4, depict two examples of a noncontact DCT 
(ncDCT) apparatus that allows for noncontact 3-D imaging 
of tissue blood flow distributions. These apparati feature a 15 
noncontact imaging probe comprised of source fibers to 
provide NIR light, such as through connection to connected 
long-coherence lasers and a detector head that features an 
array of detector fibers. The probe can be positioned within 
or around a region of interest to be imaged and near infrared 20 
12 
the advancements in 3-D image reconstruction, as well as 
that integrate with other operations to render such images. 
In DOT theory, the detected photon fluence rate <I>(r,w) in 
highly scattering media such as biological tissues obeys the 
frequency-domain photon diffusion equation 
V ( (D(r)/v) V<l>(r,w) )-(µa(r)+iwlv)<l>(r,w )�-S(r,w) (1)
where r is the position vector and v is the light speed in 
the medium. (r) is the medium absorption coefficient, and 
D(r)ssv/3µ)(r) is the medium photon diffusion coefficient 
where µ)(r) is the medium reduced scattering coefficient. (r, 
w) is the isotropic source term modulated at angular fre­
quency w. The measurements use a point source continuous­
wave (CW) approach (w=O). In DCT theory, focus is on the 
unnormalized electric field autocorrelation function, G1(r, 
-i:)=( E(r,t)E*(r,t+-i:)), obeying a formally similar CW diffu­
sion equation for DOT: 
V·((D(r)/v)VG1(r;t))-(µa(r)+ 
1hµ;(r)ka2a ( L1.r2(i:)) )Gl (r,,)�-S(r)i'=j-,) (2)
light is applied through the source fibers and to the tissue where r is the position vector and v is the light speed in 
surface through a set of optical lenses. Following diffusion the medium. µa(r) is the medium absorption coefficient, and 
through the tissue, the detector fibers detect the diffused D(r)ssv/3µ'/r) is the medium photon diffusion coefficient, 
light, via a second set of optical lenses, which in turn allows µ's(r) is the medium reduced scattering coefficient, "t is 
for measurement of the diffused light traveled through the 25 autocorrelation delay time, c is speed oflight in vacuum, and 
tissue. As set forth in FIGS. 3 and 4, such systems allow for A is wavelength. In practice, only the modulus is considered 
obtaining data without having the system contact the tissue with the right-hand side then resembling Eq. 1 in CW form 
or even the subject being imaged. As described herein, the (i.e., -S(r)). Next is written µa d(r,-i:)=1hµ)(r)k/a( &-
2(-i:)), 
detector array can vary from a linear array to a 2-D array. having the same unit as µa(r) and stemming from the 
Further, the ncDCT system can be connected to motorized 30 common referral to 1hµ)(r)k/a(&-2(-i:)) (i.e. V·((D(r)/v) 
stages such that it can scan over the region of interest (ROI) VG1 (r,1:))-(µa(r)+µad(r,1:))Gl(r,1:)=-S(r)e"
2=d,J) as the 
either rotationally (FIG. 3) or linearly (FIG. 4) to achieve a "dynamic absorption" of correlation with delay time -i: due to 
composite of multiple scans for 3-D image reconstruction. dynamic processes. ko is the wave number of the incident 
Such an approach, provides a somewhat lengthy sampling light field. a is the unitless ratio of dynamic scatterers to 
time C-tens of minutes) but reducing the cost (e.g., using less 35 total (dynamic and static) scatterers. ( llr(-i:)) is the mean-
sources and detectors). By contrast, a ncDCT system that square displacement in time -i: of the moving scattering 
features a 2D array of APDs does not require scanning, particles (e.g., red blood cells); for the case of diffuse 
thereby reducing the sampling time C- a few seconds) but motion, (llr(-i:))=6DB(r)"t where DB(r) (unit: cm
2/s) is an 
increasing instrumentation cost and dimension by requiring effective diffusion coefficient of the moving scatterers. Thus, 
more sources and detectors. 40 the dynamic absorption is redefined to µa d(r,)=2µ)(r)k0 
2aDB 
The present invention further provides, in part, for sys- (r)"t. The combined term aDB(r) is referred to as the blood 
terns and methods of using such that detect spatial speckle flow index in tissues and can be extracted by fitting the 
intensity fluctuations in diffused NIR light. These spatial analytical solution of Eq. 2. 
speckled contrast advancements feature the introduction of Proper algorithms for the forward/inverse solutions to Eq. 
a charge-coupled-device (CCD) as the detector array within 45 2 can therefore be employed to reconstruct flow index 
the system, thereby providing a 2-D detector array capable contrast. The FEM framework has been applied to model 
of rapidly acquiring a 3D image. As seen in FIGS. 5 and 6, light transportation in comprehensive diffuse media to 
the scDCT and nc_scDCT systems provide for semi-non- resolve the geometry and heterogeneity limitations for DOT. 
contact or noncontact reflectance 3-D imaging of tissue Exploiting the high mathematical similarity of the forward 
blood flow distributions. The scDCT system shown in FIG. 50 and inverse problems (e.g., boundary condition and math-
s is a semi-noncontact system (sources are still contacting ematical assumptions) between DOT (Eq. 1) with CW 
the tissue, primarily at the perimeter or boundary of the source and DCT (Eq. 2), the application of FEM in DCT is 
region of interest to be imaged with the CCD detector not in achieved. This concept is introduced into the FEM-based 
contact with the tissue), whereas the nc_scDCT system light transport and image reconstruction modules from NIR-
shown in FIG. 6 is a fully noncontact system that utilizes 55 FAST as a shortcut for FEM implementation. NIRFAST is a 
different approaches for providing the sources that do not publically available image reconstruction package based on 
require contact ( e.g. multiple sources arranged around the the diffusive model and FEM method for DOT. DCT then 
CCD or through redirection by a Galva mirror). can be conceptualized as a formulation of DOT which with 
Finite-Element-Method (FEM) Based Facilitation of CW computes G 1 (r,-i:) instead of <I>(r,w ), by updating µa(r) to 
ncDCT Image Reconstruction 60 µa(r)+µad(r,-i:), and reconstructing µa(r)+µad(r,-i:) instead of 
The present invention also provides for new algorithms, µa(r) only. The correlation function can be simulated using 
software and computing systems incorporating such that multiple delay times and combining all G1(-i:) along the time 
facilitate the processing of data generated by the imaging sequence "t. Reconstructed (r)+µa d(r,-i:) then enables extract-
systems discussed herein. Specifically, FEM-based alga- ing the flow index aDB(r) through the definition of µa d(r,-i:). 
rithms for DOT are innovatively modified for the accom- 65 As a result, the realm of DCT becomes available for com-
plishment of DCT in tissues with arbitrary boundaries. The prehensive imaging under arbitrary geometries and optical 
present invention further incorporates systems that execute properties. 
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Image reconstruction from spatial speckled contrast sys­
tems (e.g. scDCT/nc_scDCT) can similarly be achieved as 
FEM-based ncDCT. For a certain CCD camera exposure 
time, T, the spatial speckle contrast, K, is defined as the ratio 
of the standard deviation, a, to mean, µ, intensities across 
pixels in a chosen window (e.g. 7x7), i.e., K=a/µ. Using the 
Siegert relationship, this spatial speckle contrast parameter 
K can be related to the normalized temporal electric field 
autocorrelation function gl by 
14 
system that provides measurements of deep tissue blood 
flow without contacting the tissue. NIR diffuse correlation 
spectroscopy (DCS) has recently emerged as a highly advan­
tageous blood flow monitoring modality, but requires con­
tact-based interaction with the sample or tissue being exam­
ined. Such contact measurements can promote 
hemodynamic variations induced by compression or disturb 
sensitive areas. 
(3) 10 
The present invention provides an apparatus and a method 
of utilizing DCT without contact (ncDCT) for 3-D flow 
imaging of deep tissue (FIGS. 3 and 4). The present inven­
tion addresses the disadvantages associated with contact­
based DCT systems, partially through a motorized stage for 
automated and customizable ROI scanning capabilities. The 
where � relates detector and speckle size. We substitute in 
the form of gl from the analytical solution to Eq. 1 for 
semi-infinite geometry and find a nonlinear relationship 
between speckle contrast and BFI, i.e., K2=f(aDB,T,µwµs',
A,�,S-D,ko) where S-D is source-detector separation. We 
then minimize the squared difference between the experi­
mentally measured speckle contrast and theoretical result, 
(K2-f)2, with respect to extracting the blood flow index
(BFI). These calculated BFI's are then representative of the 
boundary measurements for insertion into the modified 
NIRFAST program as developed previously for FEM-based 
ncDCT blood flow reconstructions. 
The present invention further provides a smear correction 
algorithm that can be employed to correct point-source 
illumination contributions during image capture with the 
frame transfer CCD and reflectance measurement setup. 
Briefly, the speckle contrast obtained from a frame transfer 
CCD camera may be deviated from the theoretical presence 
by intensity disorder from the frame transfer process. More 
specifically, visual stripes (smears) can be induced extend­
ing from bright features in the image into the direction 
opposite that of the charge transfer process. Along this 
direction, the smear can be corrected using an algorithm 
described by Eq. 4. The actual pixel intensity signal of the 
x'h colunm and y'h row (x,y) can be restored by the measured 
value i'(x,y) with 
i(x,y)�i'(x,y)-ritr/nPTLn_/-
1i(x,n) (4) 
where tr, is frame transfer time, nP is number of pixel rows 
when the frame has moved to the readout buffer, and ri is the 
efficiency with which photoelectrons are generated during 
the charge-transfer process relative to the efficiency with 
which photoelectrons are generated during the image cap­
ture period. In the examples herein, the CCD frame transfer 
time is -1 ms with set 7x7 windows at the same distance to 
the source location for a symmetric intensity distribution, 
leading tori value of 0.67. 
Preprocessing of raw CCD images is required as follows. 
Spatial speckle contrast contributions due to hardware noise 
(i.e., shot noise and dark noise) are accounted for correcting 
the speckle contrast computation, Kmeas=(a!µ), of win­
dowed regions. Briefly, dark images are used to mitigate 
speckle contrast influences from dark noise, Ic=I-In, where 
I is the original intensity of a single pixel and In is the 
intensity of dark current. The shot noise of le follows 
Poisson statistics, (Ic)=v'(Ic), which are incorporated into 
the correction calculation. The shot and dark corrected 
speckle contrast is then given by 
15 invention further provides a finite-element-method (FEM) 
based facilitation of DCT image reconstruction of blood 
flow distribution, which may be integrated into other sys­
tems, such as an open software package for diffuse optical 
tomography (DOT) termed NIRFAST. Validation of the 
20 system is demonstrated herein through computer simula­
tions and a phantom testing design allowing flow variations. 
The present invention provides a noncontact probe that 
utilizes at least two identical laser source paths and at least 
one detector path for ncDCT (FIGS. 3 and 4). The source 
25 fiber applies NIR light through the first set of optical lenses 
to the tissue and the detector senses the applied light after it 
has diffused through the tissue. In each source path, output 
from a multimode fiber connected to a laser is projected onto 
the tissue phantom surface through lenses. The numbers of 
30 source and detector paths can be varied as needed. A detector 
fiber head in the detector path contains single-mode fibers 
equally arranged in a line covering a pre-determined range 
though lenses at desired working distance. The photons 
traveling through the sample are collected by a detector 
35 array of APDs through the detector path. The array may be 
linear or multi-linear. A multi-channel autocorrelator board 
takes the APD outputs and simultaneously calculates the 
temporal autocorrelation functions for each of S-D pairs. 
Another facet provides the integration of a motorized stage 
40 for automatic and precise ROI scanning through probe 
translation. 
FIGS. 3 and 4 show a possible apparatus arrangement for 
a ncDCT system that provides 3-D imaging of deep tissue 
blood flow distribution without contacting the tissue. Two 
45 sets of optical lenses project source and detector fibers 
respectively onto the tissue surface. The separation of source 
and detector paths then allows for the arrangement of large 
source-detector distances (up to 3 cm), thus providing for 
probing deep tissues up to -1.5 cm depth. This noncontact 
50 design allows for noninvasive hemodynamic assessment of 
tissues, such as ulcerous tissues, which overcome the contact 
limitations ( e.g., the infection of wounds). Further, as 
depicted in FIGS. 3 and 4, a linear array of APDs (e.g., 15 
APDs) and two laser sources connected to a mobile lens-
55 focusing system provide automatic and noncontact scanning 
of flow in a region of interest (ROI). These boundary 
measurements can then be combined with a FEM-based 
facilitation of ncDCT image reconstruction for arbitrary 
CT2(/)- CT2 (/D)- �(/c) 
µ2(/c) 
(SJ tissue geometry (as discussed herein), which can be then 
K= 
Noncontact DCS/DCT 
The present invention provides in part for noncontact 
measurement methodologies (ncDCS/ncDCT) for the char­
acterization of tissue blood flow within deep tissue. FIGS. 1 
and 2 show a possible apparatus arrangement for a ncDCS 
60 pioneered and integrated into a system, such as the open 
software package NIRFAST that was designed originally for 
DOT34. Initial validation efforts for the innovative ncDCT
system have been made using computer simulations, tissue 
phantoms, mammary tumors, and ulcerous tissues (see also 
65 EXAMPLES section herein). 
FIG. 13 provides examples of application of this ncDCT 
in computer simulations and using a tissue-like phantom 
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with anomaly flow contrast design
33. The cylindrical tube­
shaped anomaly was clearly reconstructed in both simula­
tion and phantom arrangements. Recovered and assigned 
flow contrast changes in anomaly were found to be highly 
correlated. These results exhibit application of ncDCT for 
3-D imaging of deep tissue blood flow heterogeneities.
16 
The ncDCT imaging system has also successfully been 
utilized on mammary tumors in human subjects (FIGS. 14 to 
27)35. ncDCT scanning procedures across the ROI (e.g., a 
breast tumor), similar to those described in the phantom 10 
experiments except that the breast tumor was scanned using 
lens is used to adapt a ROI with different areas. The 
CCD-based spatial diffuse speckle contrast DCT (scDCT)
apparatus and method of use thereof combines the benefits
of CCD detection with the FEM-based DCT flow recon­
struction discussed herein. Hundreds of S-D pairs provided
by the CCD allow one skilled in the art to omit a probe
scanning phase, significantly improving the spatial and 
temporal resolution, and reduce equipment complication,
dimension, and cost.
Application to reflectance tomographic imaging is pro­
vided by the present invention through the development of 
a robust technique that combines the benefits of CCD 
detection and FEM-based DCT flow reconstruction41 -43.
a rotational probe around the nipple. The breast tumors were 
first determined by ultrasound imaging, then scanned by the 
ncDCT probe. After DCT data acquisition, another scanning 
was done with a commercial 3-D photogrammetric camera 15 
(NextEngine, CA, USA) producing a boundary surface with 
corresponding marks. This surface was extended into a solid 
model using SolidWorks® and S-D locations were aligned 
The imaging process can be simplified by converting the 
speckle contrast to boundary flow indices and retaining the 
leverage of FEM-based DCT reconstruction advancements. 
This unique method, termed speckle contrast DCT (scDCT), 
facilitates 3-D flow contrast imaging of complex turbid 
media (see e.g. FIG. 5)4°. As this technique promotes
incorporation of both heterogeneous optical properties and 
arbitrary tissue boundaries, scDCT utilizes highly represen-
on the model surface (see, e.g., EX. 3 herein). This solid 
model was next converted to a solid mesh in ANSYS®. The 20 
mesh and S-D spatial coordinates were then finally input 
into the modified NIRFAST software enabling 3-D tomo­
graphic reconstruction of blood flow contrast36-38.
To further investigate the application of the noncontact 
systems, the ncDCS system has been examined on free 
tissue transfer flaps where eight free flaps were elevated in 
patients with head and neck cancer (see FIGS. 7-12, EX. 1 
herein)39. Multiple measurements probing the same region
of the transferred tissue were continually performed before 
and during surgery as well as on postoperative days. Post­
operative blood flow values were normalized to the intra­
operative baselines ( assigning '1 ') for the calculation of 
relative BFI change (rBF). FIG. 11 shows the results from all 
eight cases including seven successes (Cases 1 to 7) and one 
failure (Case 8). Interestingly, rBF changes/recoveries in the 
unsuccessful flap during and post vessel anastomosis were 
found to be smaller than all successful flaps, suggesting the 
potential of ncDCT measurements for early prediction of 
ischemic flaps. 
2-D Source-Detector Array 
The ncDCT system discussed above primarily concerns a
linear array of photodiodes to detect diffused NIR light. 
Such a linear array can be systematically moved across a 
region of interest to capture data set for 3D flow image. 
Those skilled in the art will appreciate that using a 2-D 
detector array that obtains data along two axes at once 
removes or reduces the need to move the detector array. 
While the mechanical scanning of a linear S-D fiber array in 
ncDCT to cover a ROI provides a way to increase sampling 
density and reduce cost, these approaches involve increases 
in the time required for measurement and may be therefore 
prone to the presence of motion artifacts. The present 
invention therefore further provides for modification of the 
ncDCT system that features a 2-D replacement of the linear 
APD array (e.g. 2-D array of APDs, such as 15x15 APDs), 
alleviating ROI scanning and cutting the acquisition time 
from tens of minutes to a few seconds to minutes. Those 
skilled in the art will appreciate that the number of APDs 
(both in length and width of the detector array) present can 
be adjusted to accommodate the region of interest. 
CCD-Based Speckle Contrast Diffuse Correlation 
Tomography (scDCT) 
tative sample characteristics in the recovery of accurate flow 
data. This scDCT technique is applied on a reflectance-based 
measurement which more adequately represents the situa-
25 tion encountered in larger subjects such as humans where 
transmission is not practical in most cases ( due to the limited 
penetration depth of light), enhancing translatability. A 
smear correction algorithm is also provided herein that 
assists to resolve the influences on data uniquely incurred 
30 when using frame-transfer CCDs with the point-source 
illumination and reflectance setup. 6
Testing the scDCT for 3-D imaging of deep flow distri­
bution in tissue phantoms with an anomaly is depicted in 
FIG. 5 and FIGS. 28 to 31. A cube-shaped solid anomaly 
35 (flow=O) with -7 mm side length was submerged -2 mm 
beneath the surface of an Intralipid liquid solution (flow;,O). 
A square metal holder positioned four source fibers in 
contact with the liquid surface (FIG. Sa). An optical switch 
distributed laser light (830 nm) into the four source fibers 
40 (Sl to S4), sequentially. The configuration of anomaly 
placement, sources, CCD detection area, and field of view 
(FOY) is shown in FIG. 31b. Reconstructed 3-D and 2-D 
cross-sectional views of the anomaly flow contrast are 
shown in FIG. 3lc and FIG. 31d, respectively, which meet 
45 our expectations. 
Noncontact scDCT (nc_scDCT) 
As with APDs, the systems utilizing CCD as a 2-D 
detector array can be utilized in a manner that avoids contact 
with the tissue being imaged. Such a system is referred to 
50 herein as noncontact speckle contrast DCT (nc_scDCT). The 
scDCT system itself, exemplified in FIG. 5, is a semi­
noncontact system (i.e., sources remain in contact with the 
tissue). A fully noncontact scDCT system (i.e., nc_scDCT) 
can be achieved by using multiple source fibers that are 
55 positioned around the CCD (such as affixed to the exterior 
of the CCD lens as seen in FIG. 6a) or one source coupled 
to a Galva mirror (see e.g. FIG. 6b). Both remove the need 
of contact between the sources and the tissue. FIG. 6c shows 
an example of a typical source-detector distribution diagram 
60 for this system. 
Sources and Detectors Alignment on 3-D Tissue Model-
ing 
The present invention further provides for a 2-D detector 
array comprised of a charge-coupled-device (CCD) that also 
allows for data acquisition along 2 axes, thereby removing 65 
or reducing the need to move the capturing detectors to 
obtain data for the region of interest. An adjustable zoom 
To render an image using the ncDCT system, first the 
imaging probe is set at the desired working distance (as used 
in the EXAMPLES herein, such a distance is -10 cm) from 
the tissue area to be imaged. The autocorrelation function at 
each sampling location is then taken while also automati-
US 9,861,319 B2 
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cally scanning the probe linearly (see, e.g. Lin et al., App. 
Phys. Lett. 104: 121103 (2014)) or rotationally (see e.g., 
Huang et al. App. Optics 54: 8808-8816 (2015)). The width 
of the region of interest with the systems exemplified herein 
is typically around 4 cm wide. Next, boundaries of the 5 
targeted area are obtained by a commercial 3-D camera. A 
model of the tissue is then created with an arbitrary surface 
using a 3-D CAD software program, followed by the align­
ment of sources and detectors to the surface of the 3-D 
model. The boundary flow index is then fitted from the 10 
obtained autocorrelation function for each S-D pair at each 
sampling location. Collected data are then entered into 
modified FEM-based software (e.g., NIRFAST) for 3-D 
flow image reconstruction. 
In instances of performing nc_scDCT, following setup of 15 
the system and ensuring both source and detectors are 
focused at the target surface, the surface intensity image 
alternatively for each source location should be obtained. 
Then, the boundaries of the target may be taken by a 
commercial 3-D camera. Tissue is then modeled with an 20 
arbitrary surface in 3-D CAD software and the sources and 
detectors are aligned on the surface of the 3-D model. Then, 
the intensity image is corrected for smeared intensity and the 
speckle contrast K and correct related noises are calculated 
as discussed above. The boundary flow index for each 25 
detector from K is then fitted and flow index information of 
the S-D set is combined with the forward and inverse 
solutions from NIRFAST for 3-D flow image reconstruction. 
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EXAMPLES 
Ex. 1: Noncontact Diffuse Optical Assessment of 
Blood Flow Changes in Head and Neck Free 
Tissue Transfer Flaps 
The custom-made ncDCS system for the noncontact mea­
surement of tissue blood flow is shown in FIG. 1. A 
noncontact optical probe is held by a platform connected to 
a linear motorized stage. A multiple axis stand holder 
provides free movements to adjust the location and incident 
angle of the probe. A DCS flowmetry is controlled by a 
laptop for continuous monitoring of tissue blood flow as 
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FIG. 2(a) shows the details of the noncontact probe 
structure. The source fiber (WF200/220/245, CeramOptec, 
Massachusetts) connected to the long-coherence laser is 
projected onto the tissue surface through achromatic lenses 
[FIG. 2(b)]. The detector fiber bundle [FIG. 2(a)], including 
California), are equally arranged in a 7-mm line to cover a 
20-mm range through the magnification of lenses. The
source and detector fibers are aligned to focus on the tissue
surface.
Photons emitted from the laser are injected through the 
source path into the tissue sample. Only a few photons 
traveling through the sample can be eventually collected 
through the detection path by the linear detector array of four 
APDs. The four source-detector (S-D) distances are set as 
10.0, 15.7, 22.8, and 30.0 mm [FIG. 10]. According to the 
diffuse theory, the photon penetration depth is about half of 
the S-D distance.28-30 Thus, for the probe structure described
above, corresponding light penetration depths range 
approximately from 5 to 15 mm. The correlator takes the 
four APD outputs and calculates the light intensity autocor-
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relation functions, which are used to extract tissue blood 
flow information. The sampling rate of DCS measurement is 
1 Hz. 
Details about DCS theory and data processing have been 
described in literature.21•22•26•27•31•32 Briefly, light intensity
fluctuation with time detected by APD is associated with the 
motion of red blood cells in tissue microvasculature and can 
be quantified by the decay of the intensity autocorrelation 
function calculated by the autocorrelator. From the normal­
ized intensity autocorrelation function, the electric field 10 
temporal autocorrelation function is determined, which sat­
isfies the correlation diffusion equation in highly scattering 
media.16 By fitting the electric field autocorrelation curve to
an analytical solution of correlation diffusion equation with 
a semi-infinite medium geometry, a blood flow index (BFI) 15 
is extracted.30 The relative change of blood flow (rBF) can
be calculated by normalizing the time-course BFI data to the 
baseline value taken before physiological changes to be 
studied. 
Most previous DCS measurements were based on a 20 
continuous manner, either with contact19•22•32-36 or noncon­
tact26"27 probes, to quantify blood flow changes without 
variation of the DCS device in long period intervals. In this 
study, however, we intended to measure the same flap at 
different days with the noncontact probe. In order to inves- 25 
ti gate ncDCS stability with this noncontinuous measurement 
protocol, the ncDCS probe was first tested on a homogenous 
liquid phantom placed in an aquarium. The tissue-like liquid 
phantom comprised Intralipid (Fresenius Kabi, Sweden), 
distilled water, and India ink (Black India, Massachusetts) 30 
and has been used extensively for DCS calibrations.37
Intralipid particles provide control of scattering (µ)) and 
Brownian motion (flow) while India ink controls absorption 
(µa). We set µa=0.05 cm-
1 and µ)=7.0 cm-1. We measured
the same liquid phantom once a day over seven days. We 35 
also tested the stability of ncDCS measurements on the 
forearm of a healthy subject in a similar manner. For each 
measurement in a day, flow data were taken for 2 min from 
the same location of the phantom/forearm with the same 
ncDCS probe. The flow values measured over seven days 40 
were normalized to the first day, representing flow variations 
over a week. 
Blood Flow Measurement Protocol of Free Tissue Trans­
fer 
20 
pedicles were attached in either an end-to-end or an end-to 
side configuration using venous couplers. 
TABLE 1 
Patient demographic and reconstruction information 
Patient Number Age Gender 
Pl (case 1) 63 
P2 (case 2) 65 
P3 (case 3) 54 
P4 (case 4) 46 
PS (case 5) 64 
P6 (case 6) 74 
P7 (case 7) 74 
P7 (case 8) 74 
Note: 
RFFF, radial forearm free flap. 
ALT, anterior lateral thigh free flap; 
FFF, fibula free flap. 
M 
M 
M 
F 
F 
M 
F 
F 
Type of flap Successful flap? 
RFFF y 
ALT y 
ALT y 
RFFF y 
RFFF y 
RFFF y 
RFFF y 
FFF N 
Approximately 30 min after anastomosis of these vessels, 
a second optical measurement was performed at the location 
of the transferred tissue within the head and neck ( oral 
cavity, orbit, or neopharynx) [FIG. 7(b)]. In addition, mul­
tiple optical measurements probing at the same location of 
the transferred free tissue were performed on postoperative 
days 2, 4, and 7 in a similar fashion to the intraoperative 
measurement after anastomosis [FIG. 7(c)]. FIG. 7 illus­
trates the protocol of blood flow measurements performed 
specifically for the reconstruction of an oral cavity defect 
(P7). In each setting, optical measurements were taken with 
the ncDCS optical probe directed toward the cutaneous 
surface of the reconstructed tissue and were kept at the same 
working distance and spot throughout the protocol. During 
intraoperative measurements, we took photos using a cam­
era to record the locations of the ncDCS source. Note that 
the focused light source point (785 nm) on the tissue surface 
can be recorded by the camera. For postoperative measure­
ments, we tried our best to align our probe to cover the same 
region of the flap. DCS data collection time for each 
measurement was approximately 2 min at a sampling rate of 
1 Hz. 
Data Analysis 
The BFI data (2 min) obtained from the four S-D dis-
Seven patients with head and neck cancer undergoing free 
tissue transfer participated in this study as part of their 
oncologic extirpation and reconstruction procedure at the 
University of Kentucky hospital. Written consents were 
obtained from all patients as well as the healthy subject (as 
45 tances of ncDCS during the operation at the intraoperative
flap elevation step and on the three postoperative days (i.e., 
days 2, 4, and 7) were normalized to the averaged BFI 
baseline values (assigning "1") taken at -30 min after flap 
50 
anastomosis, yielding rBF. The 2-min rBF data were then 
averaged to generate mean rBF values at four S-D distances, 
respectively. Finally, the mean standard deviation of the rBF 
values at four S-D distances were calculated to represent the 
rBF value and corresponding flow heterogeneity across the 
a control for the forearm measurement) in accordance with 
approval by the University of Kentucky's Institutional 
Review Board. In total, eight free flaps were elevated on the 
seven patients. Patient 7 underwent a flap that failed ( case 8) 
and another subsequent successful flap ( case 7). Details for 
patient demographic and reconstruction information are 
listed in Table 1. All free flaps were raised in a usual 
manner.38 After complete elevation of the flap with only the
main arterial pedicle and venae comitantes remaining 
attached to its native blood supply, an optical measurement 
using the ncDCS probe was performed [FIG. 7(a)]. After 60 
this measurement, the arterial pedicle and venae comitantes 
were ligated. The appropriate free flap was inset to recon­
struct the corresponding head and neck defects and the 
venous and arterial pedicles were anastomosed to recipient 
vessels from the external carotid system and internal jugular 65 
venous system. Each arterial pedicle was anastomosed in an 
end-to-end configuration using 9-0 nylon sutures. Venous 
55 measured bulk flap tissue. Statistical tests for averaged rBF
differences at different time points were performed using 
one-way repeated measures AN OVA with main effects of the 
time period. p value<0.05 was considered significant for 
statistical results. 
Results 
FIG. 8 shows relatively smaller changes in flow over 
seven days measured from the liquid phantom [FIGS. 8(a)-
8(d)] and healthy forearm [FIGS. 8(e)-8(h)]. Flow variations 
over days measured at all S-D pairs were fairly constant, 
indicating the stability of ncDCS for non-continuous mea­
surements. By averaging rBF (or relative flow in the phan­
tom) values over the four S-D separations, we found that the 
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largest flow variations were only 1.09±0.23 from the phan­
tom and 1.13±0.24 from the forearm (mean±standard devia­
tion). 
By contrast, remarkably larger rBF variations were 
observed from all patients over the seven days. FIG. 9 shows 
illustrative results measured from one typical successful 
case (case 1) and the failure case (case 8). FIG. 10 shows the 
average results over the seven successful cases; significant 
differences were found among the flow responses obtained 
from the four separations (one-way ANOVA test, p<0.001). 10 
Although heterogeneous flow responses at different S-D 
pairs existed due to the tissue heterogeneity at different 
depths and regions of tissues, the trends of blood flow 
alterations measured at different S-D separations were fairly 
consistent in each case (FIG. 9) and over subjects (FIG. 10). 15 
We then calculated bulk blood flow in the flap by aver­
aging DCS data obtained from the four S-D detectors, which 
represented the overall flap hemodynamics better than that 
from a local tissue volume detected by a single S-D pair. 
FIG. 11 shows these results from all eight free flap cases 20 
including seven successes ( cases 1 to 7) and one failure ( case 
8). Larger variations in rBF were observed in all patients at 
all measurement time points. In the group data of successful 
cases, an initial decrease of the blood flow was observed 
intraoperatively (from the elevation of free flap to the end of 25 
vessel anastomosis), followed by a graduate flow recovery 
during the following postoperative days. By contrast, rBF 
changes/recoveries in the unsuccessful flap during and post 
vessel anastomosis were smaller than all successful flaps. 
For better comparison, the averaged rBF values over the 30 
seven successful flaps as compared to the unsuccessful flap 
(case 8) are shown in FIG. 12. For the group data of seven 
successful flaps, average intraoperative rBF at the time of 
flap elevation was 1.71±0.12 (mean±standard error). Aver­
age postoperative rBF on postoperative days 2, 4, and 7 were 35 
1.89±0.15, 2.26±0.13, and 2.43±0.13 (mean±standard 
error), respectively. The rBF variations over all measure­
ment time points were significant (one-way ANOVA test, 
p<0.001). By contrast, rBF values observed from the unsuc­
cessful flaps were 0.82, 1.14, and 1.34, respectively, at the 40 
time of flap elevation and on postoperative days 2 and 4, 
which were apparently lower than the successful cases. 
Discussion and Conclusions 
This study focused on evaluating the microvascular cir­
culation of free flaps both intraoperatively and postopera- 45 
tively using a novel ncDCS technique. Due to previous 
blood flow measurements using DCS or ncDCS performed 
mostly in a continuous manner, 19•22•26•27•32-36 a challenge of
this study was the quantitative stability of the non-continu­
ous measurements over several days. To facilitate a quanti- 50 
tative comparison during perioperative monitoring period (7 
days) in the protocol, rBF (or relative flow) in the liquid 
phantom with a stable flow and in the healthy forearm were 
monitored by ncDCS once a day over one week. 
The results demonstrated fairly stable flow values during 55 
the non-continuous measurements (see FIG. 8). The mean 
flow variations over the four S-D pairs during the measure­
ment period were less than 9% (phantom) and 13% (fore­
arm), respectively. By contrast, the results shown in FIGS. 
9-12 indicated significantly larger flow variations in the 60
reconstructed flaps over the perioperative measurement
period. The perioperative variations of blood flow in the
elevated flaps meet the expectation of physiological
responses to any surgical insult. There is almost always an
initial drop of blood flow after vessel anastomosis as fresh 65
flaps are ischemic.39 The postoperative continuous increase
in rBF results from the gradual recovery of tissue injuries
22 
associated with the decrease of vascular resistance in those 
elevated flaps.7 Depending of the degree of ischemia and the 
amount of time before recovery of blood flow, the flap will 
either die or recover.39 Interestingly, blood flow in the
unsuccessful case did not show either the initial drop of 
blood flow after vessel anastomosis or the postoperative 
recovery. Although more cases need to be performed, the 
observed perioperative differences in blood flow between 
the unsuccessful and successful flaps (see FIGS. 11 and 12) 
demonstrate the potential of ncDCS measurements to predict 
early free flap failures. 
Our results are comparable to data available in literature 
obtained using other technologies such as laser Doppler8 and 
ultrasound Doppler.4-6 For example, intraoperative
decreases in blood flow after flap anastomosis6•8 and post­
operative increases/recoveries in blood flow/velocity4•5•8 
were observed, which are similar to our results (see FIGS. 10 
and 12). A previous case study also reported lower blood 
flow after anastomosis in an unsuccessful flap.6 In addition,
preliminary results from a pilot study showed the potential 
of blood flow measurements using laser Doppler to predict 
flap failure before other clinical signs.8 However, in contrast
to ultrasound or laser Doppler technology that focuses on 
evaluating blood flow/velocity in large vessels or superficial 
tissues, the nature of ncDCS measurement is to quantify 
blood flow changes in deep tissue microvasculature.20•26 
Since appropriate blood flow in tissue microvasculature is 
the key for the survival of flaps,49•41 ncDCS may become a
useful tool with more sensitive measurements than the 
ultrasound/laser Doppler technology in monitoring tissue 
flap vascularity. The ncDCS technology is feasible for 
perioperative measurements of tissue blood flow in all flaps 
included within this study, despite the anatomical challenges 
that these flaps present intraoperatively and postoperatively. 
These findings are encouraging as this technology may offer 
surgeons the ability to assess tissue blood flow in real time 
during the surgery, immediately after vessel anastomosis, as 
well as in the early postoperative period when flap compro­
mise is the highest. A prominent advantage of the ncDCS 
system is the use of its noncontact probe, which allows 
measurements to be taken under nonsterile conditions. It 
also avoids potential distortion in blood flow signals result­
ing from contact-probe compression on the target tissue. 
Furthermore, the noncontact probe is able to assess blood 
flow over the reconstructed tissue without interfering with 
the sterility of the surgical fields and the surgical setup. 
Several challenges have arisen in the early implementation 
and use of this device. The complex anatomical configura­
tions of head and neck reconstructions and patients' limita­
tions have been successfully addressed. For example, flaps 
used to reconstruct the oral cavity are difficult to assess fully. 
Adaptations by measuring through the intact skin and sub­
mental tissues up to the reconstruction tissue have shown 
promise ( cases 5 and 7). Practically, tissue blood flow can be 
assessed approximately up to 15 mm below the skin surface 
with this current model of the DCS system (i.e., half of the 
maximum S-D distance of 30 mm). 
However, tissue congestion and edema may affect light 
penetration and blood flow measurement, which needs fur­
ther evaluations using tissue-simulated phantoms.42 In this
study, tissue blood flow was measured by ncDCS intraop­
eratively and postoperatively. During intraoperative mea­
surements, the patient was anesthetized and thus there was 
no motion artifact in blood flow measurements. During 
postoperative measurements, the subject was asked to keep 
still during the short period of measurements (-2 min). We 
did not find obvious motion artifacts in postoperative mea-
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Ex2: Three-Dimensional Flow Contrast Imaging of 
Deep Tissue Using Noncontact Diffuse Correlation 
Tomography 
Blood flow distribution in tissues can provide vital infor-
surements either. Moreover, we averaged the 2-min data to 
reduce the variation during measurements. In addition, the 
potential influence of probing tissue curvature on ncDCS 
flow measurements has been previously investigated by our 
group. 27 The results revealed that curvature resulted in slight 5 
underestimation in BFI, but not in rBF. Blood flow quanti­
fication in this study was performed by ncDCS in a longi­
tudinal time frame with limited point measurements (i.e., 
four S-D pairs). We indeed observed the heterogeneity of 
blood flow responses at different depths and regions due to 10 
the tissue heterogeneity (see FIGS. 9 and 10). Ideally, 3-D 
imaging of flap would provide complete information for 
predicting the flap viability. However, our ncDCS system 
has limited numbers of sources and detectors and thus 
cannot generate a 3-D flow image. Recently, ncDCS has 
been extended in our laboratory to the noncontact diffuse 
correlation tomography (ncDCT)42 and speckle contrast
diffuse correlation tomography (scDCT).43 Both ncDCT and
scDCT have the potential to assess the spatial flow distri­
butions in deep flaps with 3-D tomographic information. 
15 
mation to healthcare professionals including clinicians and 
research investigators. Alterations in blood flow may result, 
for example, in regions of tissue presenting with ischemia 
and hypoxia. These abnormalities are associated with and 
help characterize many diseases including pressure ulcers, 
In conclusion, we were able to use the ncDCS in multiple 
and complex head and neck reconstructions with different 
free tissue transfers. ncDCS is a promising tool that may 
provide objective information regarding flap viability in 
real-time intraoperatively and in the early postoperative 
periods, thus allowing surgeons early identification of those 
compromised and ischemic flaps with the hope of salvaging 
them. 
20 stroke, and cancer. Furthermore, blood flow contrast imag­
ing can assist in applications such as cancer diagnosis and 
therapy monitoring.1 Near-infrared diffuse correlation spec­
troscopy (DCS) has emerged as a highly advantageous blood 
flow monitoring modality through inherent noninvasiveness, 
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Regional and Free Flaps for Head and Neck Reconstruction: 
as well. In these, lenses were positioned between a sample 
and optical fiber grid connected to light and detection 
elements.6 .7 
These arrangements, however, were only tested on small 
animals with limited source-detector (S-D) separations rang­
ing from 2 to 10 mm. Flexibility is minimal and expense 
increases with the scaling of the region of interest (ROI). 
Another limitation of these studies is reliance on analyti­
cal solutions assuming a simple semi-infinite geometry and 
strict heterogeneities (e.g., spherical) of tissue which pre­
cludes the transition to complex boundaries and imperfect 
heterogeneities. Complications would also become apparent 
in accommodating complex boundaries with numerous S-D 
fibers. Furthermore, in testing these types of systems, the 
imitation of flow contrast changes often relies on solid 
phantoms (no flow) embedded in liquid phantoms (Intra­
lipid; Brownian particle motion) or the converse case. This 
method lacks elegance due to the restrictively static nature 
of the components once prepared, specifically the solid 
phantom material. The current study seeks to remedy many 
of these concerns. First, we extended our noncontact DCS 
system2•4 to noncontact DCT (ncDCT) using a motorized
stage for automated and customizable ROI scanning capa­
bilities. Next, a finite-element-method (FEM) based facili­
tation of DCT image reconstruction was accomplished 
through integration into an open software package for dif­
fuse optical spectroscopy/tomography (DOS/DOT) termed 
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NIRFAST.8 Finally, validation efforts included computer
simulations and a phantom testing design allowing flow 
variations. 
Extending DCS into DCT attaches the burden of collect­
ing many boundary measurements. As such, our noncontact 5 
probe was upgraded to have two identical laser source paths 
and one detector path (FIG. 4(a)) doubling our previous 
number of available S-D pairs. In each source path, output 
from a multimode fiber (WF200/220/245, CeramOptec, 
MA, USA) connected to a laser was projected onto the tissue 10 
phantom surface through lenses.2·4 The detector fiber head
(FIG. 4(b)) in the detector path contained 15 single-mode 
fibers (SM800-5.6-125, Fibercore, CA, USA) equally 
arranged in a 7 mm line covering a 20 mm range through 
lenses at 100 mm working distance. The resulting S-D 15 
separations were in the span of 10 to 30 mm, thus allowing 
up to -15 mm penetration depth.1 Instrument operation
involves two 825 nm long coherence lasers ( coherence 
length>5 m, CrystaLaser, NV, USA) emitting photons to 
tissue through individual source paths alternatively. The 20 
photons traveling through the sample are collected by a 
detector array of 15 avalanche photodiodes (APD, Perkin 
Elmer, Canada) through the detector path. A multiple chan­
nel autocorrelator (Correlator.com, NJ, USA) takes the APD 
outputs and simultaneously calculates the correlation func- 25 
tions for the 15 S-D pairs per source.3 Another significant 
improvement was the integration of a motorized stage for 
automatic and precise ROI scanning (FIG. 4(c)) through 
probe translation. Either rotational or linear motion staging 
is available to maximally fit the subject geometry ( e.g., 30 
breast shape or slab shape). This design feature enables large 
ROI coverage and flexible S-D arrangements without greatly 
increasing hardware requirements and costs (e.g., fibers, 
APDs, and correlators). In this study, the ncDCT modality 
was motivated by the linear stage (T-LSM200A, Zaber, 35 
Canada). 
Application of DCS theory, as well as correction for 
smearing is performed using the algorithms described 
herein. To test our theoretical DCT technique through com­
puter simulations, we first evaluated forward solution accu- 40 
racy in a homogeneous situation (i.e., no anomaly). A slab 
mesh [dimension (mm): 90 (H)x90 (W)x35 (D)] was gen­
erated with total node number 73 949 simulating liquid 
phantom solution in a slab shaped container (e.g., 
aquarium). Optical properties were set throughout at 45 
µ)=8.00 cm-1 and µa =0.045 cm-
1 close to breast tissue
values.9 The slab flow indices (aDB) were set close to
Intralipid phantom values5 •10 at lxl0-8 cm2/s and corre­
spond to the background tissue. As shown in FIG. 4(c), the 
noncontact probe was scanned linearly (mimicked in simu- 50 
lation) across the ROI in 15 steps with an increment of 4 
mm/step generating a scanning area of 40 mmx56 mm and 
450 (15 stepsx15 APDsx2 sources) effective S-D pairs. The 
forward solution (i.e., Gi(i:)) was calculated by the modified 
NIRFAST with s from Oto 8xl0-6 s. Minimal simulation 55 
26 
times of the background (1 xl0-8 cm2 /s ). Reconstruction was
conducted on a second mesh with coarse finite element 
division (node number: 11 025) and the same optical prop-
erties. The delay time i:=3.2xl0-6 s was used to calculate
µa d(i:). Due to limited ROI dimensions along the tube, only 
partial anomaly reconstruction was possible (FIG. 13(a)). 
For percentage flow change comparison, the reconstructed 
anomaly peak flow value was normalized to the averaged 
step differences of aDB. Both the shape (FIG. 13(a)) and 
relative anomaly flow contrast changes (FIG. 13(b)) were 
well reconstructed (regression slope=l.00, R2=1.00, and
p<l o-5). We also used a half maximum threshold to segment 
the anomaly and then calculated its mean flow value. An 
excellent linear relationship was also observed between the 
reconstructed and assigned percentage flow changes ( data 
are not shown; regression slope=l.00, R2=1.00, and p< 
10-5). 
To evaluate the errors in depth reconstruction (localiza­
tion) of the anomaly and their dependence on the size of 
anomaly, we performed supplementary simulations using 
the existing tube and a smaller tube [6 (Dia.) mm 80 (L) 
mm]. The anomaly central depth was varied up to 16.5 mm 
beneath the surface. 
The reconstructed central depths of the tube anomalies 
and the relative changes of flow index contrasts were 
accurate when the assigned anomaly was localized in the 
sensitive region of light diffusion (i.e., anomaly central 
depth 12.5 mm; data are not shown). These simulation 
results demonstrated the robustness of the proposed FEM-
based ncDCT technique. 
We next validated the developed system in practical 
object measurements by phantom experimentation. A back­
ground of liquid phantom was placed in an aquarium (FIG. 
4(c)) and a pump-connected cylindrical tube anomaly was 
filled with liquid and small pieces of solid phantom (FIG. 
4(d)). The tissue-like liquid phantom comprised Intralipid, 
distilled water, and India ink and has been used extensively 
for DCS calibrations.4 Intralipid particles (Fresenius Kabi,
Sweden) provide control of scattering (µ)) and Brownian 
motion (DB; a""l) while India ink controls absorption (µa). 
We set µ; and µa, respectively, at 8.10 cm-
1 and 0.044
cm-1 while quantifying them with a FD tissue-oximeter
(Imagent, ISS, IL, USA).11 To create flow index contrasts
against the background, a clear plastic tube [ dimension
(mm): 13.5 (Dia.) 80 (L)] with a very thin wall (0.35 mm)
was placed at 12.5 mm (tube center to ROI surface) into the
background liquid phantom (FIG. 4). The tube was mostly
filled with small pieces of solid phantom (µ)=10.00 cm-1
and µa =0.10 cm-
1) to randomize pumped particle motions as
Brownian motion and generate a diffusive circumstance for
photons. Solid phantoms comprised titanium dioxide, sili-
con, and carbon black. A peristaltic pump (HV-77201-60,
Cole Parmer, Ill., USA) connected in series with a hydraulic
capacitor that damped fluid pulsations was employed to
create step increases in steady flow from O to 20 ml/min at
4 ml/min increments within the tube. The high percentage of
solid components (no particle motion therein) made the flow
index in the tube close to O when no flow motivation was
induced by the pump. The noncontact probe was first
aberrations over the measured ROI (1 % mean discrepancy 
and 1.45% standard deviation) were observed between aDB 
extracted using the established semi-infinite analytical solu­
tion2 of Eq. (2) and the assigned aDB. With the forward 
solution verified, the next simulation embodied recovery of 
an anomalous presence and subsequent contrasts. A cylin­
drical tube-shaped anomaly [dimension (mm): 13 (Dia.)x80 
(L)] was inserted beneath the middle of the ROI with a depth 
of 12.5 mm from the tube center to the ROI surface. The 
60 calibrated to the homogeneous liquid phantom region to
unify aDB measurement for each S-D separation. The scan­
ning procedure was linear as assumed in simulations. Total
scanning time was 20 min with 60 s sampling time per step
anomaly optical properties (i.e., µa and µ)) were matched to 65 
the background tissue. The attributed anomaly aDB was 
varied with contrast ranging from 0, 4, 8, 12, 16, and 20 
at 0.5 Hz DCS sampling rate for each laser. For each S-D
pair, the interval average (60x0.5=30 points) represents the
corresponding boundary measurement for that step. We used 
identical reconstruction parameters as the simulation includ-
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tions generated by different -i:. This may be especially true 
when the flow contrast of the imaging anomaly differs 
greatly. 
Furthermore, recruiting multiple s (assemble more equa­
tions at different time scales for each S-D pair) may promote 
robustness in solving an ill-posed inverse problem. These 
questions provide for further exploration. 
ing slab mesh and delay time t with the exception of a 
median filter application. This latter addition assisted in 
stabilizing inherent experimental noise not encountered in 
the ideal simulation.8 The relationship between macro 
pumped flow (unit: ml/min) and micro particle motion ( aD B 
unit: cm2/s) is complicated, but was confirmed linear.12 For 
this case, the assigned flow represents the macro flow (pump 
speed) rather than DCS indices. In FIG. 13(d), relative 
macro and micro flow changes were presented in the same 
way used in simulation. A tube-shaped anomaly was clearly 
recognizable after image reconstruction (FIG. 13(c)). The 
reconstructed flow indices accurately captured the flow 
changes in the tube when quantified with the peak value 
(FIG. 13(d); linear regression slope=0.97, R
2=1.00, and 
p<l o-5) and with the mean of segmented anomaly ( data are 
not shown; linear regression slope=0.99, R
2=0.96, and 
p<l o-3). The liquid phantom system provided both a cir­
cumstance of complex dynamic particles and changes of 
particle motion and possesses the potential for easily updat­
ing tissue properties in both the background and the 
anomaly. 
In conclusion, we reported a ncDCT system for 3-D flow 
contrast imaging. A FEM framework was introduced to 
10 simulate temporal electric field autocorrelation diffusive 
transport and reconstruct spatially distributed flow contrasts. 
The imaging capability of flow contrasts was validated 
through both simulations and phantom experimentation. We 
tested the ncDCT system on a simple semi-infinite geometry 
15 herein, but by incorporating other imaging modalities (e.g., 
MRI and photogrammetric scanning) arbitrary geometry can 
be obtained. The noncontact breakthrough design enables 
potential imaging of deep blood flow contrast in real human 
tissues (e.g., breast tumor, pressure ulcer) without distorting 
20 hemodynamic properties. 
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µa and µ; contrasts. We found that inaccurate µ; assump­
tions resulted in much greater flow index contrast errors than 
inaccurate µa, which are consistent with our previous find­
ings.10 Nevertheless, the relative changes of reconstructed 
flow index contrasts over a large range of property contrast 35 
variations (2- to 3-fold) were accurately reconstructed even 
with the incorrect assumptions of optical properties ( data are 
not shown). The problem of modeling such heterogeneity 
can be solved by combining DCT with other FD or time­
domain DOT imaging instruments. To our advantage, the 40 
FEM-based implementation software proposed is fully 
capable of incorporating such arbitrary heterogeneities. 
Previous DCT studies emphasized assigning a selective 
delay time t to each S-D pair based on the analytical or 
approximate solution of Eq. (2) which relies on simple 45 
geometry and optical properties as mentioned above.6 By 
contrast, we propose to use a uniform T. From the view of 
µa \t), assigning uniform t unifies the µa \t) on the same 
time scale such that t does not generate extra µa d(-i:) contrast. 
-i: (3.2xl0-6 s) was selected in this study based on a few 50 
simulations and exhaustive sensitivity optimization has not 
yet been completed. Specifically, we selected several small 
t values (-i:sl.9xl0-5 s) from the entire range (generally from 
1.0xl0-7 to 1.0xl0-3 s) to reconstruct flow contrasts in
computer simulations for comparisons. The variations in the 55 
mean values and regression slopes of flow index contrasts 
reconstructed with different s were found to be 5±10% and 
<5%, respectively (data are not shown), indicating the 
robustness of ncDCT method in this range. Note that large 
Ex. 3: Alignment of Sources and Detectors on 
Breast Surface for Noncontact Diffuse Correlation 
Tomography of Breast Tumors 
The altered tissue hemodynamics and metabolism in 
tumor pathogenesis have been well documented. It has been 
noted that the autonomic growth and spread of malignant 
tumors are partially dependent on increased angiogenesis 
arising from the increased metabolic demand 1-3. Previous 
studies in breast cancer reported that hypermetabolism and 
increased angiogenesis were linked to increased blood flow, 
total hemoglobin concentration, and tissue metabolism4-10. 
For example, positron emission tomography showed signifi-
cant tumor-to-normal tissue blood flow contrasts in breasts 
up to fivefold higher4. In carcinomas compared to benign 
lesions, flow velocities in large arteries adjacent to tumors 
acquired by Doppler ultrasound were significantly higher by 
up to threefold9. Thus, the functional imaging of tumor 
hemodynamics/metabolism is an exciting new strategy and 
provides a more finely grained and individualized under­
standing of cancer pathophysiology and treatment11 •12 . 
Near-infrared (NIR) diffuse optical spectroscopy/tomog-
raphy (DOS/DOT) is a noninvasive, portable, and relatively 
inexpensive tool for functional imaging of deep tumor 
oxygenation6-8•13-15. NIR diffuse correlation spectroscopy/
tomography (DCS/DCT) has also been developed more 
t (e.g., >l.9xl0-5 s) may lead to unstable results in recon­
structed flow indices. Based on the definition of dynamic 
absorption µa d(-i:) in Eq. (2), a large "t may result in an 
effective absorption (µa+µ/(-i:)) greater than the normal 
range of tissue absorption, thus influencing the stabilities of 
forward and inverse solutions in NIRFAST. A good -i: selec­
tion is complicated by considerations such as the occurrence 
60 recently, which is capable of imaging blood flow distribu­
tions in deep tissues16-23. Most of these diffuse optical 
techniques deliver and receive NIR light using optical fibers 
placed on top of the tissue surface. These contact-based 
approaches may be disadvantaged for in vivo measurements 
of any weight distinctions or redundancies between equa-
65 due to the distortion of tissue hemodynamics resulted from 
the compression of probe contact on soft tissues with 
irregular boundaries. To overcome this limitation, our labo-
US 9,861,319 B2 
29 
ratory has recently developed a noncontact DCS/DCT 
(ncDCS/ncDCT) system for three-dimensional (3D) imag­
ing of human tissue blood flow distribution without probe­
tissue contact24-26. A finite element method (FEM)27•28
based framework was also established facilitating ncDCT 5 
image reconstruction for tissues with arbitrary geometries26.
This ncDCT system has been tested in tissue-like liquid 
phantoms with a simple semi-infinite geometry26. During
the test, a motorized linear stage was employed to carry out 
ncDCT probe scanning over the flat surface of liquid phan- 10 
toms. However, when applying the ncDCT system for in 
vivo investigations, the system must be modified to adapt to 
complex tissue boundaries. The goal of this study was to 
adapt the ncDCT system for the use of tumor detection in 
human breasts. For this purpose, we designed a motorized 15 
rotational stage to scan over the breast tissue and used a 
commercial 3D camera (NextEngine, California, USA) to 
obtain breast surface geometry. Several challenges exist 
when inputting the geometrical information to the FEM­
based image reconstruction of ncDCT. First, the breast 20 
surface contour mesh generated by the 3D camera must be 
extended to a solid volume mesh to include the tissue 
volume imaged. Second, because the data from the 3D 
camera and ncDCT were collected in different coordinate 
systems, coregistration of the two coordinates is necessary. 25 
Finally, the projected sources and detectors of ncDCT (sev­
eral hundreds of pairs) on the breast surface must be 
precisely aligned on the surface of solid mesh for the 
accomplishment of image reconstruction. 
Computer-aided design (CAD) is a powerful tool for 2D 30 
and 3D solid modeling and coordinate transformation, and 
has been increasingly applied in the biomedical field 29•30.
The application programming interface (API) has been 
recently introduced to CAD software (e.g., SolidWorks, 
Dassault Systemes, Massachusetts, USA), which allows to 35 
access and control CAD software easily. In this study, we 
proposed a CAD-based approach to create the solid volume 
mesh from the surface contour mesh (generated by a 3D 
camera), to coregister the data obtained from the 3D camera 
and ncDCT, and finally to align the sources and detectors of 40 
ncDCT on the surface of the solid breast model. 
30 
through the detection path by a linear detector array of 15 
avalanche photodiodes (APDs, Perkin Elmer, Canada). The 
distance between the two projected sources was 40 mm and 
the resulting source-detector (S-D) separations were in the 
span of 10 to 30 mm [FIG. 3(c)]. A multichannel autocor­
relator (Correlator.com, New Jersey, USA) took the 15 APD 
outputs and calculated the light intensity autocorrelation 
functions to extract blood flow index. A linear stage 
(5236A16, McMaster-Carr, Illinois, USA) and a custom­
made rotational platform were used to manually align the 
line-shape probe at the initial scanning position of a selected 
region of interest (ROI) and approximately parallel to the 
breast tissue surface 
B. Scanning Procedure over Breast Tissue Surface. A
breast model of a plastic mannequin placed on a bed was 
first used to explore the feasibility of the scanning protocol 
over the breast. A laser pointer inside the rotation arm was 
used to align the rotation axis approximately through the 
nipple [FIG. 3(a)]. 
The optical probe was then adjusted to make the two 
source chief rays approximately perpendicular to the surface 
of the mannequin breast. The probe scanned 60 deg over a 
ROI through 21 steps with a 3-deg increment per step. Total 
scanning time was i<<25 min with 60 s sampling time per 
step at 1 Hz sampling rate for each DCS laser source. The 
projected source pairs at the 1st, 11th, and 21st steps, as well 
as the rotation center, were visually marked on the breast 
surface using a marker pen. 
After ncDCT probe scanning, the breast surface with 
marks was imaged by the 3D camera [FIG. 14(a)]. The 
camera operated at a working distance of-17 in, and with a 
field of view (FOY) of 10 inx13 in. [see the inset in FIG. 
14(a)] and an acquisition time of -2 min. The mannequin 
was then removed from the bed and a small foam pad 
perpendicular to the rotation axis was attached to the DCS 
scanner [FIG. 14(b)]. The 3D camera took another image to 
include the small foam pad as a reference plane (RP), which 
was used for the coregistration of two coordinate systems: 
3D camera and ncDCT. Note that the 3D camera was kept 
at the exact same position/location when taking the two 
images [FIGS. 14(a) and 14(b)]. 
After the feasibility test in the mannequin breast model, 
we used a similar but simplified protocol to scan over a ROI 
on a realistic human breast. A 22-year-old female subject 
We then evaluated the accuracy of source alignment on 
the breast surface as well as the influence of alignment errors 
on flow image reconstruction of breast tumor. This approach 
lays the groundwork of ncDCT for in vivo imaging of spatial 
blood flow distribution in breast tissues. 
Methods and Materials 
A. Motorized Rotational Probe for ncDCT Details about
ncDCT can be found elsewhere 26. FIG. 3 shows the 
rotational probe design of ncDCT for the imaging of tissue 
blood flow distribution in human breast. Two source fibers 
(WF200/220/245, CeramOptec, Massachusetts, USA) con­
nected to two long-coherence lasers (785 nm, CrystaLaser, 
Nevada, USA) were projected alternatively onto the breast 
surface through achromatic lenses [FIG. 3(c)]. The detector 
fiber bundle [FIG. 3(b)] consisted of 15 single-mode fibers 
(SMS00-5.6-125, Fibercore, California, USA), which were 
equally arranged in a 7 mm line to cover a 20 mm range 
through the magnification of lenses. A long-pass filter with 
a cutoff wavelength of 750 nm (FEL0750, Thorlabs, New 
Jersey, USA) was set in the detector path to reduce the 
influence of ambient light. 
45 who had a fibro-adenoma (benign tumor with no evidence of 
malignancy) in the breast volunteered to participate in this 
study after written consent in accordance with approval of 
the Institutional Review Board at the University of Ken­
tucky. The subject lay supine on the bed comfortably and her 
50 body was fixed on the bed using soft form pads and pillows 
to reduce potential body motion artifacts during measure­
ments. The tumor location was determined by ultrasound 
imaging, and the tumor mass margin along the longitudinal 
and latitudinal directions was marked on the ultrasound 
55 image. The ncDCT probe then scanned 60 deg over a ROI 
throughout 16 scanning steps with a 4-deg increment per 
step. This simplified protocol reduced the scanning time to 
-17 min. Consequently, six marks of three source pairs were
made at the 1st, 8th, and 16th steps. Following ncDCT
60 scanning, in situ breast tissue optical properties (i.e., reduced 
scattering coefficient µ; and absorption coefficient µa were 
measured at three different locations by a commercial fre­
quency-domain tissue oximeter (Imagent, ISS, Illinois, The probe head was adjusted to focus the source and 
detector fiber tips on the breast surface. Photons emitted 
from the lasers were injected alternatively through the two 65 
source paths into the tissue sample. Photons transported/ 
scattered through the sample were eventually collected 
USA). 
The averaged µ; and µa over multiple sites were used as 
initial inputs for flow image reconstruction. Finally, 3D 
camera scanning procedures were performed identically to 
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those used in the mannequin breast model as described 
above. The total measurement time in the clinical room was 
-25 min.
C. Solid Modeling of Breast Tissue Volume. For 3D flow
image reconstructions, a solid breast model/mesh including 
the tissue volumes to be imaged is required. FIG. 15 
illustrates the procedure to convert the mannequin ( or 
human) breast surface image acquired by the 3D camera to 
32 
and marked source points. The relative alignment errors 
were evaluated along the radial (Yrad) and tangential (Y,an) 
directions of the rotation by calculating the ratios of radial 
and tangential distance deviations (arad and a,an) to the 
measured radial and tangential distances Orad and !,an), 
respectively: Y,an=a,a)l,anxl00%; Yrad=arailradxl00%. 
FIG. 18 demonstrates how to quantify the relative align­
ment errors at the source mark M6. Briefly, two planes 
(Plane 1 and Plane 2) were set up to be perpendicular to the a solid volume model. The 3D camera control software 
(ScanStudio HD, NextEngine, California, USA) generated a 
3D surface mesh with three pairs of source marks and a 
rotation center mark [FIG. 15(a)]. The RP is also displayed 
10 BP. Plane 1 crossed the mark pair of MS and M6 along the 
radial direction while Plane 2 was crossing M6 and perpen­
dicular to Plane 1 along the tangential direction. a tan and 
arad were the distances from the aligned source (nearby M6) 
to the two planes, respectively. !rad and !,an were the pro-
in the figure. A non-uniform rational basis spline (NURBS) 
continuous surface was extracted by autofitting the nodes of 
the surface mesh. We then created a bottom plane (BP) 
parallel to the RP. The distance between the BP and the 
rotation center point was set as 50 mm. Finally, a solid breast 
model was generated by extruding a 2D circular contour on 
the BP along the rotation axis to the breast surface [FIG. 
15(b)]. This solid breast model including the marked ROI 20 
was eventually used to generate a 3D tissue volume mesh for 
flow image reconstruction. The volume of the solid breast 
model was determined by the area of 2D circular contour, 
the angle of the extruding, and the distance between the BP 
and the rotation center point. These parameters should be 25 
selected individually to ensure photons being diffused suf­
ficiently inside a relatively large tissue volume31 . On the
other hand, the tissue volume should be minimized to reduce 
the calculation burden for image reconstruction. 
15 jected distances on the BP from M6 to MS and from M6 to 
M2, respectively. 
G. FEM-Based Flow Image Reconstruction of ncDCT. 
Details about the FEM-based forward and inverse solutions 
of ncDCT for blood flow imaging reconstruction can be 
found in our recent publications26. Briefly, the facilitation of
DCT image reconstruction is accomplished through integra-
tion into an open software package for FEM-based DOT 
termed NIRFAST27•28. Exploiting the high mathematical
similarity of the forward/inverse problems ( e.g., boundary 
condition and mathematical assumptions) between DOT and 
DCT, we introduce a "dynamic absorption" of correlation 
D. Coregistration of the Solid Breast Model and ncDCT 30
Coordinate Systems. The breast surface imaging and ncDCT 
scanning were originally implemented in different coordi­
nate systems (FIG. 16). For the coregistration of the two 
systems, we defined the x-y plane of the ncDCT coordinate 
system at the BP and z-axis along the rotation axis of the 35 
ncDCT. The coordinate of the rotation center was thus at (0, 
with delay time due to dynamic processes of moving scat­
terers (primarily red blood cells). DCT can then be concep­
tualized as a modified formulation of DOT, which computes 
autocorrelation function instead of photon fluence rate. For 
computer simulations, the autocorrelation function can be 
generated using multiple delay times ( e.g., 60 -i: was used in 
this study) in the forward solution. For imaging reconstruc­
tion, the blood flow distribution can be extracted using the 
measured boundary data at multiple S-D pairs in the inverse 
solution. 
0, 50 mm). The initial scanning position of the ncDCT linear 
array was aligned to the ncDCT system by adjusting the two 
source rays through the source marks made at the first step. 
This coregistration procedure allowed us to place the solid 40 
breast model into the ncDCT coordinate. 
3. Results
A. Solid Models with Aligned Sources and Detectors
The mannequin breast model and the human breast were
used to demonstrate the CAD-based approach described 
earlier. FIGS. 19( a )-19( c) illustrate the modeling procedures 
and results obtained from the mannequin breast model. The 
3D NURBS surface image [FIG. 19(a)] was transformed to 
the solid volume mesh by ANSYS (ANSYS, Pennsylvania, 
E. Alignment of Sources and Detectors on the Surface of
the Solid Breast Model. For FEM-based ncDCT image 
reconstructions, sources and detectors must be projected on 
the breast tissue surface. We employed the CAD method 
operated by API to define a scanning plane (SP) perpen­
dicular to the BP and passing through the initial pair of 
source marks [Ml and M2, FIG. 17(a)] and to mimic the 
probe scanning procedure over the breast surface. 
Each source or detector path in the SP was simplified as 
a single chief optical ray [FIG. 17(b)] perpendicular to a 
crossing straight line (Ml to M2). The two sources were 
located at -L/2 and L/2 along the crossing line of length L 
and the 15 detectors spanned in the range of -L/4 to L/4. We 
then projected the sources and detectors along the chief 
optical rays onto the surface of the solid breast model. The 
projected points of intersection on the breast surface repre­
sented the aligned sources and detectors at the initial scan­
ning step. The SP with source and detector rays was repeat­
edly rotated around the rotation axis for projecting sources 
and detectors at all scanning steps onto the surface of the 
solid breast model. 
F. Evaluation of Source Alignment Errors. To characterize
the alignment errors at different scanning steps, we quanti­
fied the distance from the aligned source points to the 
corresponding source marks. The absolute alignment error 
(a: mm) was measured by the distance between the aligned 
45 USA) with an average node distance of 2 mm [FIG. 19(b )] . 
The sources and detectors were then aligned on the surface 
of volume mesh [FIG. 19(c)]. Similarly, FIGS. 19(d)-19(t) 
illustrate the modeling procedures and results obtained from 
an in vivo human breast. The resulting volume meshes 
50 [FIGS. 19(c) and 19(1)] with sources and detectors aligned 
on their surfaces can be input into NIRF AST27•28 for ncDCT
image reconstructions26.
B. Source Alignment Errors
Table 2 summarizes the measured radial and tangential
55 distances Orad and !,an) at different source marks as well as 
corresponding absolute and relative alignment errors of the 
sources on the surfaces of mannequin and human breast. For 
both cases, the absolute errors (a) increased with the 
increase of scanning step, which is expected as the align-
60 ment was calibrated on the first pair of source marks (Ml 
and M2). On average, the absolute error observed in the 
human breast (0=2.64±1.65 mm) was larger than that in the 
mannequin breast ( =0.79±0.50 mm). The mean relative 
error in the tangential direction (Y,an=4.56±2.18%) was 
65 larger than that in the radial direction (Yrad=2.43±1.17%), 
indicating the major contribution of tangential errors to the 
alignment errors. Similarly to the absolute errors, y tan 
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increased with the increase of scanning step and its mean 
value in the human breast (5.63±2.44%) was larger than that 
in the mannequin breast (3.50±1.48%). 
TABLE 2 
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blood flow contrasts were 16.2-fold and 11.3-fold, respec­
tively. The ultrasound image [FIG. 20(d)] shows a tumor 
with the dimension of 19.0 mmx18.3 mm at the central 
Absolute and Relative Alignment Errors between tbe Projected Sources 
and the Original Source Marks on the Manneguin and Hwnan Breasts 
Case Marks o(mm) a,an (mm) !,an (mm) Y,an (%) (Jrad (mm) lrad(mm) Yrad (%) 
Mannequin M3 1.34 0.23 9.24 2.48 1.06 
M4 1.25 0.64 23.87 2.68 0.75 
MS 1.79 0.84 14.79 5.67 1.04 
M6 2.56 1.43 45.03 3.17 1.09 
Human M3 1.11 0.90 22.38 4.02 0.52 
M4 2.28 1.56 39.80 3.92 1.64 
MS 4.20 3.83 41.96 9.13 0.32 
M6 6.26 4.26 78.27 5.44 0.46 
C. Impact of Source and Detector Alignment Errors on
Flow Image Reconstruction 
In order to evaluate the impact of alignment errors on 
imaging reconstruction of blood flow contrast, computer 
simulations were conducted on the mannequin breast [FIG. 
20(a)]. A sphere anomaly with a radius of 5 mm was 
assigned to be 8 mm beneath the surface of the breast to 
mimic a breast tumor. A solid mesh was created with 4 mm 
node distance and was refined to 1 mm node around the 
known anomaly region (-20 mm radius) to improve detec­
tion resolution while not overwhelmingly increasing the 
number of nodes. For simplicity, optical properties for both 
anomaly and background were set throughout the tissue at 
µa =0.06 cm-
1 and µ)=6 cm-1. The flow indices for back­
ground and anomaly were set as lxl0-8 cm2/s and 5xl0-8
cm2/s, respectively, resulting in a relative flow contrast 
(rBF) of five-fold between the anomaly (tumor) and sur­
rounding nodes (healthy tissues). We then assigned align­
ment errors of 10% in the rotation angles (i.e., 3.3° instead 
of 3°) for all sources and detectors at all scanning steps. For 
example, the source alignment errors at MS and M6 were: 
Ytan=l0.55%; Yrad=2.04% and Ytan=9.85%; Yrad=4.93%, 
respectively. The levels of these errors are consistent with 
our experimental results shown in Table 2. The impact of 
alignment errors on the tumor location and blood flow 
contrast was evaluated by comparing the reconstructed 
results with and without alignment errors. 
FIGS. 20(b) and 20(c) show the reconstructed anomaly 
using the sources and detectors without and with alignment 
errors, respectively. The reconstructed anomaly centers 
deviated 1.30 mm (without alignment errors) and 2.07 mm 
(with alignment errors) from the assigned original coordi­
nate [FIG. 20(a)], respectively. The shift of the anomaly 
central location (0.77 mm) was less than the node distance 
35.33 3.00 
2.12 
32.46 3.20 
3.35 
39.20 1.32 
4.18 
34.61 0.92 
1.33 
depth of 13.0 mm beneath the breast surface. FIG. 20(1) 
20 shows the reconstructed tumor projected on the surface of 
the breast, which agrees with the tumor location on the x-y 
plane determined by the ultrasound image. 
4. Discussion and Conclusions
Most DCT measurements used optical fibers in contact
25 with tissues for photon emission/collection and required
tissues to conform to simple boundaries such as a slab. The 
compression on the tissue may introduce distortions in tissue 
hemodynamics33. An obvious solution to this problem is to 
30 place the sources and detectors away from the interface,
allowing for the noncontact imaging of arbitrary boundaries. 
We have recently developed a noncontact DCT system and 
have demonstrated its feasibility for 3D imaging of flow 
contrasts in tissue phantoms with a simple flat surface26. Our
35 ultimate goal is to translate this ncDCT system from bench­
top to clinics for imaging of in vivo tissues with complex 
geometries such as human breasts. 
This reports a critical step toward the translation of the 
ncDCT system for in vivo imaging of breast tumors. Cur-
40 rently, a variety of methods exist for obtaining irregular 
tissue geometries. Previous studies for DOT have used 
magnetic resonance imaging (MRI)
28•34•35 and computer
tomography (CT)36 to obtain solid volume meshes for imag­
ing reconstruction. Hybrid systems combining DOT and 
45 MRI have also been reported recently37-40. However, the 
high cost, large instrumentation, and poor mobility of MRI 
or CT are major limiting factors for their frequent use in 
clinic. Only a few studies used 3D cameras to generate tissue 
surface geometries for DOT. For example, Dehghani et al. 
so employed a 3D camera to scan over human breast surface 
before placing the source and detector fibers on its surface41. 
Obvious deformation of breast tissues was observed after 
placing the optical fibers for the contact DOT measurements. 
(1 mm). When using a full width half maximum (FWHM) 
threshold to segment the anomaly32, the mean values of 55 
reconstructed flow contrasts were 5.63-fold and 5.68-fold, 
respectively. Thus, the deviation of average rBF contrasts 
caused by alignment errors was less than 1 %. 
Previous fluorescence tomography studies in small animals 
(mouse or rat) used a 3D camera or CCD camera to acquire 
animal surface geometry, where the animals were either 
fixed in a small chamber42•43 or rotated over 360 deg44•45.
However, translation of these methods from small animals to 
humans is not straightforward since many constraining 
factors associated with human subjects must be considered, 
such as safety, flexibility, and comfort. 
D. In Vivo Breast Tumor Reconstruction Using ncDCT 
FIG. 20(e) shows the reconstructed 3D flow contrast 60 
image of tumor inside the patient's breast using the FWHM 
threshold to segment the tumor. The central depth and 
dimension of the reconstructed tumor were 9.7 mm and 16.9 
mmx15.5 mm, respectively. The measured µa andµ; of the 
breast tissue using the Imagent were 0.04 cm-1 and 7.8 cm-1,
respectively, which were used as inputs for flow image 
reconstruction. The peak and averaged tumor-to-normal 
Our study utilized a 3D camera to obtain the surface 
geometry of the breast. The 3D camera can be placed at the 
bedside close to the subject, which makes the operation 
65 flexible in clinical rooms. The fully noncontact measure­
ments by both 3D camera and ncDCT guarantee subject 
safety and comfort. The CAD-based approach with API 
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allows us to convert the 3D surface profile to the 3D solid 
model, coregister the two coordinate systems (i.e., 3D 
camera and ncDCT), and align automatically the sources 
and detectors of ncDCT on the surface of the solid breast 
model. 
36 
the mesh node distance (1 mm) and the deviation of recon­
structed flow contrast due to the alignment errors was less 
than 1 %. Thus, the impacts of alignment errors on flow 
image reconstruction are ignorable. 
Most of previous studies used a software such as Net­
gen28, iso2mesh46, or Matlab43 to generate a volume mesh
from the surface mesh obtained by a 3D camera47 or
CCD 44. The source and detector locations on the surface of
volume mesh were determined by ray tracing on the indi­
vidual surface mesh nodes. Therefore, the accuracy of S-D 
alignment depended on the distance and distribution of 
surface mesh nodes. By contrast, we aligned the sources and 
detectors directly on the continuous surface (NURBS), 
which was extracted by auto fitting the nodes of the surface 
mesh using CAD tools. Therefore, our alignment did not rely 
on the surface nodes. Furthermore, the CAD-based align­
ment method used in this study mimicked the same scanning 
procedure of the ncDCT probe, thus providing an easy way 
to assess the performances of scanning and alignment. 
The results from the patient with tumor demonstrate the 
feasibility of ncDCT in clinical use. The average tumor-to­
normal blood flow contrast of 11.3-fold observed in this 
study is comparable to previously reported flow contrasts of 
2- to 10-fold in breast tumors detected by DCS 10•48, noticing
10 that tumor blood flow contrasts quantified by DCS may be
underestimated due to the partial volume effect. In addition,
the potential cross talk between µa, µ;, and blood flow may
also result in overestimation or underestimation of blood
15 flow contrasts
49. When assuming homogeneous µa andµ)
over the entire breast, the realistic heterogeneous µa and µ; 
over the tumor can generate errors in tumor blood flow 
contrast. To overcome this limitation, a separate DOT instru­
ment enabling 3D imaging of µa and µ; distributions in the 
20 breast is needed
50051 .
The reconstructed tumor central depth of 9.7 mm is 
slightly shorter than the ultrasound finding (13.0 mm). This 
is likely due to the deep location of the tumor, which is 
slightly beyond the sensitive depth of diffuse light detected 
25 by our current ncDCT system. Based on photon diffuse 
theory, the penetration depth of diffuse light is -1/2 of the S-D 
separation [ 49]. The largest S-D separation of current 
ncDCT is 30 mm, allowing for a penetration depth up to -15 
mm. It is thus not surprising that the reconstruction errors
The accuracy of S-D alignment on the breast model is 
critical as it affects the accuracy of flow image reconstruc­
tion. Note that for simplicity the alignment accuracies in this 
study were characterized based only on the representative 
sources marked at the initial, middle, and final steps. We 
observed in this study that maximal alignment errors over 
scanning steps were less than 10%; i.e., 5.67% (mannequin) 
and 9.13% (human) in the tangential direction, and 3.35% 
(mannequin) and 4.18% (human) in the radial direction 
(Table 2). On average, the relative errors in the tangential 
direction were larger than those in the radial direction for 
both mannequin and human breasts, and the tangential errors 
increased with the increase of scanning step. These are 
expected since any imprecision of mechanically rotational 
scanning by the ncDCT probe should result in larger tan- 35 
gential errors along the rotation direction compared to the 
radial errors. Furthermore, the tangential errors may be 
accumulated with the increase of scanning step. By contrast, 
the radial errors are generally not accumulative as the length 
30 increased as the tumor ( dimension based on ultrasound 
image: 19.0 mmx18.3 mm) center was located at a depth of 
13 mm. In addition, noises from clinical measurements may 
also contribute to the reconstruction errors. 
of the rigid scanning arm is fixed. In addition, perpendicu- 40 
larity between the rotation axis and the breast surface may 
also affect the alignment accuracy. The mechanical scanning 
errors can be reduced by using a high-precision motorized 
stage and the non-perpendicularity may be corrected by 
using an intelligent system to adjust the scanning axis based 45 
on a dynamic scanning of breast surface geometry. 
It is also not surprising that the tangential errors observed 
in the human breast are larger than those found in the 
mannequin breast because some influencing factors may not 
For the verification, we conducted computer simulations 
with the same size/location of a spherical anomaly (diam­
eter=18 mm) as the human tumor and similar level of 
measurement noises. We observed that the reconstructed 
anomaly was located at -10. 9 mm beneath the breast surface 
with a diameter of 15.1 mm (data are not shown), which 
fairly agreed with our in vivo measurement results (i.e., 
tumor central depth=9.7 mm and dimension=16.9 mmx15.5
mm). 
The focus of this study was to develop a CAD-based 
approach to align the sources and detectors of ncDCT on the 
surface of breast volume mesh for blood flow image recon­
struction. We evaluated the accuracy of the source align­
ments using computer simulations and on a plastic manne­
quin and an in vivo human breast. Although we reported 
only one in vivo human case in this paper as an example, 
more simulations and in vivo imaging results from human 
breasts have been recently published by our group52.
Theoretically, ultrasound imaging is not a part of ncDCT 
setup. However, given that fact that our ncDCT is the first 
optical imaging system providing 3D blood flow contrast 
distributions in breast tumors, we do need to compare our 
results with other standard imaging modalities (such as 
ultrasound photography) for validation. Also, ultrasound 
imaging of breast tumors helps us to determine the region of 
be well controlled in human subjects, such as the irregular 50 
shape of a real breast as well as a subject's breathing or 
moving during the ncDCT measurement. However, the total 
averaging time of 60 s for blood flow measurement at each 
scanning step has greatly reduced the influence of a subject's 
breathing. To reduce potential motion artifacts resulted from 55 
body motion, we can re-mark source positions immediately 
after the body motion occurs and use difference marks for 
the alignment. Integration of all marked source positions for 
the alignment can increase the alignment accuracy, which 
will be the subject of our future work. 60 interest for ncDCT scanning. In addition, a priori knowledge 
of tumor location and volume can improve flow contrast 
reconstruction [52], which will be the subject of our future 
work. 
Computer simulations are commonly used to evaluate the 
performance of an imaging system. In this study, the impact 
of alignment errors on image reconstruction was determined 
by quantifying the deviations of central location and flow 
contrast of the assigned tumor inside the breast. The devia- 65 
tion of the reconstructed anomaly location (0.77 mm) result­
ing from the alignment errors was found to be smaller than 
In conclusion, we have developed a motorized rotational 
probe for ncDCT imaging of breast tissues and a CAD-based 
approach for the alignment of sources and detectors on the 
surface of solid breast models. The generated breast volume 
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mesh along with the boundary data collected from the 
aligned sources and detectors can be used for FEM-based 
flow image reconstruction. 
The results indicate that relative source alignment errors 
on both mannequin and human breasts are less than 10% 5 
throughout all scanning steps, which result in minor impact 
on flow image reconstruction. The recovery of in vivo breast 
tumor demonstrates the feasibility of ncDCT for clinical 
applications. Furthermore, the ncDCT system has the poten­
tial to be used for the imaging of deep blood flow distribu-
10 tions in a variety of soft or vulnerable tissues ( e.g., breast 
tumor, pressure ulcer, burned tissue). 
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Ex. 4: Noncontact Diffuse Correlation Tomography 
of Human Breast Tumor 
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mograms offer substantial benefit for early cancer detection. 
However, mammography is hampered by a significant false­
positive rate, which is especially high for women with dense 
breast tissue. 
The dense breast population is a particularly important 
subset of women because they experience higher incidence 
and mortality rates from the disease.1 ·2 Other imaging diag­
nostic tools for breast cancers include x-ray computed 
tomography (CT), magnetic resonance imaging (MRI), posi­
tron emission tomography (PET), and ultrasonography.3-5 
Most of these imaging methods are prohibitively expensive 
and generally only provide tumor morphological informa­
tion with low specificity. Moreover, some of these tech­
niques (e.g., CT and PET) expose patients to ionizing 
radiation. 6 .7 
The autonomic growth and spread of malignant tumors 
are dependent on increased angiogenesis arising from the 
increased metabolic demand. 8 Since functional alternations
in tumors often appear earlier than detectable morphological 
changes, functional imaging of tumor hemodynamics and 
metabolism is a new strategy for early cancer diagnosis.
9 
Near-infrared (NIR) diffuse optical technologies provide a 
noninvasive and relatively inexpensive tool for functional 
imaging of tumor hemodynamics in deep microvasculature 
up to several centimeters.10-13 
The most commonly used NIR diffuse optical spectros­
copy/tomography (DOS/DOT) can quantify total hemoglo­
bin concentration (THC) and blood oxygen saturation 
(St02) in tumors. 14015 DOS/DOT has been used over several
decades to detect oxygenation alternations in breast 
tumors.16-2° For example, THC was found up to 2-fold
higher in malignant lesions than nearby healthy tissues.15 
More recently, a novel NIR diffuse correlation spectroscopy 
(DCS) technique has also been developed for direct mea­
surement of blood flow index (BFI) in deep tissues.21 
A few pilot studies of breast tumors using DCS have 
found increased blood flow inside the tumor in contrast to 
surrounding normal tissues.10 Real-time monitoring of 
breast tumor blood flow response to neoadjuvant chemo­
therapy also demonstrated the potential of DCS for assessing 
cancer therapies.22 ·23 
Despite advances in DCS technologies, there have been 
limited imaging applications of diffuse correlation tomog­
raphy (DCT) for tumor detection. An early probe-tissue 
contact-based DCT approach was applied to tissue phan­
toms24 but was disadvantaged in vivo due in part to com-
pression-induced hemodynamic alterations. A few noncon­
tact-based DCT examinations have been conducted using 
the camera lenses positioned between a sample and optical 
fibers connected to source and detection elements.25 ·26 
These arrangements, however, were only tested on the brain 
of small animals with limited probing depth (<5 mm). 
Another limitation of these imaging studies was their reli­
ance on analytical solutions that assumed a simple semi­
infinite flat tissue geometry. 
Our group has recently developed a novel noncontact 
DCT (ncDCT) system enabling three-dimensional (3-D) 
imaging of deep tissue blood flow distribution without 
contacting the tissue.21•27•28 Our ncDCT system employs
two sets of optical lenses to project source and detector 
fibers, respectively, onto the tissue surface. The separation of 
source and detector paths allows for the arrangement of large 
source-detector distances, thus enabling probing deep tis­
sues up to centimeters. Furthermore, a finite-element-
The current clinical standard for breast screening is x-ray 
mammography, with recent evidence confirming that mam-
65 method (FEM) based facilitation of ncDCT image recon­
struction for arbitrary tissue geometry is pioneered and 
integrated into an open software package (NIRFAST), 
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designed originally for DOT.29 Initial validation efforts for 
the innovative ncDCT system have been made using com­
puter simulations and tumor-like phantoms on a simple 
slab-shaped tissue boundary (i.e., semi-infinite geometry).
21 
This reports our first step to adapt the ncDCT system for 
in vivo imaging of blood flow distribution in human breast 
tumors. We used a commercial 3-D camera (NextEngine, 
California) to obtain breast surface geometry and then 
converted it to a solid volume mesh for ncDCT image 
reconstruction. 
Computer simulations were carried out to characterize the 
performance of an ncDCT system for imaging an anomaly 
(tumor) with varied flow contrasts and depths inside the 
tissue volumes under different surface boundaries. The 
malignant tumors inside human breasts ( determined by 
ultrasound imaging) were then scanned using the ncDCT 
probe, and high tumor-to-normal flow contrasts were 
observed in the reconstructed images. To the best of our 
knowledge, we demonstrate, in this report, the first 3-D 
blood flow contrast imaging of human breast tumors using 
the noninvasive ncDCT. 
Materials and Methods 
Noncontact Diffuse Correlation Tomography System 
Instrumentation 
As reported previously,21 our ncDCT probe is a lens­
focused apparatus, which has two identical source paths and 
one detector path configured in a linear array. In each source 
path, output from a multimode source fiber (WF200/220/ 
245, Ceram-Optec, Massachusetts) connected to a laser (825 
nm) on the DCS instrument is projected onto the tissue 
through lenses. Fifteen single-mode detector fibers (SM800-
5.6-125, Fibercore, California) are equally spanned in the 
detector path connected to a detector array. The source­
detector (S-D) separations vary from 10 to 30 mm, thus 
enabling up to -15 mm penetration depth.21 Two long 
coherence lasers at 825 nm ( coherence length>5 m, Crys­
taLaser, Nevada) emit light to tissue through individual 
source paths, alternatively. 
The photons traveling through the tissue sample are 
collected by the detector array of 15 avalanche photodiodes 
(APD, Perkin Elmer, Canada) through the detector path. A 
multichannel autocorrelator (Correlator.com, New Jersey) 
takes the APD outputs and calculates 15 correlation func­
tions simultaneously. A motorized stage was integrated into 
the optical system, which rotates the ncDCT probe around 
the nipple for scanning a region of interest (ROI) on the 
breast surface. The outcomes from this scanning are the 
boundary data of intensity autocorrelation functions col­
lected at hundreds ofS-D pairs on the ROI (see the example 
in FIG. 25). 
Diffuse correlation spectroscopy/diffuse correlation 
tomography principle and noise model was utilized using the 
algorithms described herein. 
FIGS. 21 and 22 illustrate the main commands executed 
for solving the forward and inverse problems, respectively, 
in ncDCT using modified NIRFAST. A homogeneous back­
ground tissue volume mesh with assigned initial optical 
properties of µa(r) and µ)(r) is first generated in the forward 
solution (see FIG. 21). All S-D pairs corresponding to the 
actual or simulated scanning of ncDCT probe are placed on 
the surface of the background mesh. However, only those 
with valid links between sources and detectors are config­
ured as effective pairs for image reconstruction. An anomaly 
region (mimicking a tumor) inside the background volume 
mesh is then defined and assigned a BFI contrast relative to 
the surrounding background. Based on the designed distri­
butions ofBFis, µa'
0'a1(r, -i:) is updated for each voxel inside 
40 
the entire tissue volume within a certain range of -i:. The 
autocorrelation functions Gi(r, -i:) for multiple t from all 
effective S-D pairs are then calculated by running the 
forward model. The boundary BFI data at all effective S-D 
pairs are then extracted by fitting G1(r, -i:) to the analytical 
solution of Eq. (2) under semi-infinite homogeneous geom­
etry. It is noted that even though the forward problem 
simulates the light propagation in breast tumor models, 
some commands (e.g., "Run forward model . . .  ") are also 
10 executed for experimental data reconstruction. 
To evaluate noise influence on image reconstruction 
through simulations, randomized noise varying at different t 
is generated based on a noise model originally derived for 
DCS.32•33 The noise level depends on the detected photon 
15 count rate (i.e., light intensity) at each S-D pair, which is 
estimated using the light intensity detected from in vivo 
breast tissues (see Sec. 2.3). This noise is applied to the 
simulated gir, -i:) curves. Multiple gir, -i:) curves with noise 
are generated for each S-D pair and then averaged to 
20 improve the signal-to-noise ratio (SNR). This simulation 
mimics our in vivo measurements and data averaging pro­
cess in human breasts. Finally, gir, -i:) curves are converted 
to Gi(r, -i:) curves to generate boundary BFI data. 
Solving the inverse problem for image reconstruction is 
25 conducted on a second mesh with a coarse finite element 
division (pixel basis)29•34 (see FIG. 22). Initial values of
background BFI and optical properties [µaCr) and µ)(r)] 
along with the selected -i: ( -i:=t 1 was specifically noted herein) 
are assigned to generate a homogeneous inverse mesh. The 
30 simulated or measured boundary BFI data are converted to 
g1(r, -i:) at the selected t using the semi-infinite analytical 
solution ofEq. (2),27033035036 and further converted to G1 (r, -i:)
by multiplying with Gi(r, 0). The boundary Gi(r, -i:) is then 
input into the inverse model to reconstruct the µa'
0'a1(r, -i:) 
35 distribution inside the entire tissue volume. The BFI distri­
butions are finally extracted through the definition of µa d(r, 
-i:). 
Computer Simulation Protocols 
We conducted several computer simulations to character-
40 ize the performance of the ncDCT system. The first simu­
lation tested the abilities of ncDCT in recovery of an 
anomaly (tumor) beneath the surfaces of a slab and a female 
plastic mannequin breast (see herein). The second simula­
tion evaluated the reconstruction accuracies of the anomaly 
45 with varied depths and flow contrasts in the same plastic 
mannequin breast. The influence of noise on ncDCT image 
reconstruction was also assessed and compared with the 
results without noise. The last simulation applied a priori 
structural knowledge of the anomaly in the inverse mesh to 
50 improve the accuracy of flow image reconstruction. 
Reconstructions of a tumor in slab-shaped and breast­
shaped tissues 
To evaluate the reconstruction of an anomaly inside a 
background tissue volume with a simple semi-infinite geom-
55 etry, a slab volume [dimension (mm): lOO(H)xlOO(W)x40 
(D)] was first generated in SolidWorksR (Dassault Sys­
temes, Massachusetts) and then segmented into finite 
elements using ANSYSR (ANSYS, Pennsylvania). A total 
of 15,996 nodes were created with node distances of 3 and 
60 6 mm in the ROI and the surrounding region, respectively 
[FIG. 23(a)]. Different mesh resolutions were employed to 
reduce the total node number while maintaining appropriate 
spatial resolution in the ROI. The segmented mesh nodes 
and elements information were then input into MATLABR 
65 (Math Works, Massachusetts) to generate all mesh files 
needed for the simulations with modified NIRFAST. The 
slab volume mesh represented a healthy background tissue 
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volume. A spherical anomaly with a diameter of 10 mm 
mimicking a tumor was then placed at the ROI center, and 
the anomaly centroid location was 7 mm beneath the surface 
of background tissue volume [FIG. 23(a)]. Optical proper­
ties for both tumor and background tissues were set homo­
geneous throughout the entire slab as µ)=6.00 cm-1 and
µa =0.06 cm-
1 .
The blood flow indices for the background and anomaly 
were set as lxl0-8 cm2/s and lOxl0-8 cm2/s, respectively,
resulting in a 10-fold flow contrast between the tumor and 10 
surrounding normal tissues [FIG. 23(c)]. The ncDCT probe 
with a linear S-D array scanning rotationally over the ROI 
was simulated for 21 steps with 3 deg/step to collect the 
boundary data [FIG. 23(a)], where coordinates were calcu­
lated with MATLAB. There were a total of 42 sources and 15 
315 detectors distributed on the ROI. Thus, 630 (315x2) S-D 
pairs were effectively available and used for image recon­
struction. The autocorrelation functions G 1 (r, -i:) from the 
effective S-D pairs were calculated by the modified NIR­
FAST software with t ranging from O to 3.2xl0-5 s (50 20 
consecutive t). Reconstruction was conducted on the same 
mesh with a pixel basis of 20x20x25 and a -i:1 =8.7xl o-6 s.
The t selection has been discussed in our previous publica­
tion.21 The presenting anomaly was extracted with the
full-width at half-maximum (FWHM) criterion37 on the 25 
reconstructed DCT image. The averaged BFI and the center 
location of the reconstructed anomaly were computed by 
averaging the BFis and node coordinates within the 
anomaly. 
In order to assess the ability of ncDCT for imaging a 30 
tumor inside breast, we conducted a computer simulation on 
42 
breast tumors with their centroid locations within the sen­
sitive region of diffuse light (i.e., the detected penetration 
depth ofNIR light is -1/2 of the S-D separation)35•38·39 were
our most interested study population, since more reliable 
reconstructions can be generated. At each depth, the tumor­
to-normal flow contrast was increased from 0- to 20-fold at 
5-fold increment/step. The reconstructed tumor depth was
characterized as the shortest distance from the reconstructed
anomaly center to the breast mesh surface.
The measurement accuracy of the ncDCT system was 
assessed by quantifying the discrepancies between the 
reconstructed and assigned values in tumor central location 
and flow contrast. 
To evaluate the noise influence on image reconstruction, 
we added noise on the subsets of boundary data collected 
from the tumor with 10-fold flow contrast throughout all 
varied depths. Forty gir, -i:) curves with noises were gen­
erated and averaged at each effective S-D pair for DCT 
image reconstruction. 
Reconstruction with a Priori Knowledge of Tumor Loca­
tion and Volume 
To improve the reconstruction accuracy of anomaly blood 
flow contrast, the soft-constraint method37•40-42 in NIRF AST
package was tested in this simulation. A priori structural 
information of tumor (i.e., central location and tumor vol­
ume) was included in the inverse mesh by labeling the nodes 
in the inverse mesh according to the regions of tumor or 
surrounding tissues. A regularization matrix L was applied to 
the penalty term in the minimization function for the DCT 
inverse problem, which was equivalent to applying a Lapla­
cian-type filter to minimize variation within each region. 
Simulations were done with the spherical anomaly (10-
fold flow contrast and diameter=lO mm) placed at either 7 
or 15 mm central depth beneath the breast surface and with 
or without noise. 
In-Vivo Blood Flow Imaging of Human Breast Tumor 
To explore the feasibility of an ncDCT imaging system in 
clinical applications, two female patients with low-grade 
carcinoma were recruited from University of Kentucky 
a female plastic mannequin breast. The surface geometry of 
the mannequin breast with source marks of ncDCT was 
scanned by a commercial 3-D camera (NextEngine, Cali­
fornia), which was further converted to a solid breast tissue 35 
volume using Solid Works. To align the sources and detec­
tors of ncDCT on the breast model surface for image 
reconstruction, a scanning plane perpendicular to the breast 
surface and crossing the optical rays of 2 sources and 15 
detectors was created in SolidWorks. 
The scanning plane was first aligned passing through the 
first pair of source marks and then rotated step-by-step 
around the rotation axis with an angle increment of 3 deg, 
matching our experimental procedure [FIG. 23(a)]. At each 
step, the sources and detectors along the optical rays were 45 
projected onto the surface of the solid breast model. 
40 Comprehensive Breast Care Center, with signed informed 
consent approved by the University of Kentucky Institution 
Review Board. The patient lay in a supine position and the 
major tumor lesion inside the breast was determined by 
Similar to the slab meshing, the solid breast volume was 
segmented into finite elements with node distances of 3 and 
radiologists using ultrasound imaging prior to the optical 
measurement. The tumor mass margins along the radio 
direction were marked on the ultrasound images. 
The ncDCT probe was driven by a step motor to scan 
rotationally around the breast nipple over the region of 
breast tumor. The scanning procedures were similar to those 
described herein. Briefly, 15 and 21 scanning steps were 
taken to cover the tumor bearing regions in the two breasts, 
respectively. 
Forty gir, -i:) curves were collected from each S-D pair for 
each patient, and two source pairs at the beginning and 
ending steps of scanning were visually marked on the breast 
surface as the references for the alignment of sources and 
detectors on the surface mesh. The surface geometry of the 
breast with the source marks was then recorded by the 3-D 
camera for image reconstruction. Following the ncDCT 
6 mm in the ROI and surrounding region. A solid volume 
mesh [largest dimension (mm): 100(H)x78(W)x(70(D)] 50 
with total nodes of 14,717 was generated for simulations. A 
spherical tumor with a diameter of 10 mm and a node 
distance of 3 mm was then placed at the ROI center, and the 
tumor centroid location was 7 mm beneath the breast surface 
[FIG. 23(e)]. For comparisons, we assigned the same optical 55 
properties and BFI contrast as those used in slab-tissue 
simulation. The boundary data were also collected in the 
same manner over the ROI on the breast surface. Identical 
breast-shaped mesh with a pixel basis of 20x20x30 and 
-i:1=8.7x10-
6 s were used for image reconstruction. 60 measurement, a commercial frequency-domain tissue oxi­
meter (Imagent, ISS, Illinois )43 was used to measure µ; and
µa of the breast tissue at three different locations. The 
averaged µ; and µa over the multiple sites were used as 
Quantification of Tumor Location and Flow Contrast in 
the Breast-Shaped Tissue 
This simulation used the same tumor model in the breast-
shaped mesh with the same configuration and optical prop­
erties [see FIG. 23(e)]. The tumor was placed beneath the 65 
surface of the breast-shaped mesh with varied central depths 
from 7 to 15 mm at 1 mm increment/step. It is noted that 
initial inputs for flow image reconstruction. 
The solid breast mesh of the patient was created in the 
same way as that of the plastic mannequin breast. Boundary 
BFis on the breast mesh surface were then extracted by 
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fitting the measured gir, i:) curves from effective S-D pairs. 
These boundary BFI data were then calibrated to the BFis 
collected at the first scanning step, where the tissue under­
neath the probe was outside the tumor region and thus 
assumed to be homogeneous and healthy. The calibrated 
boundary data were finally used for DCT image reconstruc­
tion. 
Results 
Noncontact Diffuse Correlation Tomography Recovered 
an Anomaly Inside Both Slab-Shaped and Breast-Shaped 
Tissue Volumes with Similar Accuracies in Simulations 
FIG. 23 illustrates 3-D [FIGS. 23(a), 23(b), 23(e), and 
23(1)] and two dimensional (2-D) cross-section [FIGS. 
23(c), 23(d), 23(g), and 23(h)] views of blood flow distri­
butions in the slab-shaped (top panel) and breast-shaped 
(bottom panel) tissue volumes, respectively. FIGS. 23(a), 
23(e), 23(c), and 23(g) show the originally assigned/simu­
lated anomaly inside tissue volumes and FIGS. 23(b), 23(1), 
23(d), and 23(h) show the reconstructed results for com­
parisons. 
44 
FIGS. 24(d) and 24(e) demonstrate the linear relation­
ships between the assigned and reconstructed peak and 
average BFI contrasts. The relative anomaly flow contrast 
changes were well reconstructed from the chosen central 
depths of 7 mm (peak BFI: linear regression slope=l.03, 
R2=0.99, and p<0.001; average BFI: linear regression
slope=l.02, R2=0.99, and p<0.001), 10 mm (peak BFI:
linear regression slope=l.01, R2=0.97, and p<0.01; average
BFI: linear regression slope=l .00, R2=0.97, and p<0.01), 13 
10 mm (peak BFI: linear regression slope=l.07, R2=0.98, and
p<0.01; average BFI: linear regression slope=l .07, R2=0.98,
and p<0.01), and 15 mm (peak BFI: linear regression 
slope=l.08, R2=0.98, and p<0.01; average BFI: linear
regression slope=l.08, R2=0.98, and p<0.01). The relation-
15 ships between the assigned and reconstructed relative 
anomaly flow contrast changes from other tested depths 
were similar (results not shown here). 
In total, these results indicate that relatively higher accu­
racies were achieved when the entire anomaly was within 
20 the sensitive depth of diffuse light. Also, even though the 
recovery of anomaly BFI contrasts was not as accurate as its 
location, the reconstructed anomaly BFI contrast changes 
were fairly accurate. 
To clearly visualize the anomaly inside the tissue volume, 
3-D background meshes were presented with 30% transpar­
ency of their original colors. The reconstructed anomalies
were presented with FWHM thresholds in 3-D images
[FIGS. 23(b) and 23(1)] and without thresholds in 2-D 25 
cross-section views [FIGS. 23(d) and 23(h)]. Table 3 sum­
marizes the discrepancies between the assigned and recon­
structed anomalies inside the slab-shaped and breast-shaped 
tissue volumes. These results indicate that the ncDCT sys­
tem can recover the anomaly inside both slab-shaped and 30 
breast-shaped tissue volumes with similar accuracies. 
Noise Reduced Anomaly Recovery Accuracy in Simula­
tions 
FIG. 25 shows the ncDCT image reconstruction results 
with simulated noise added to the forward problem. For 
comparisons, images reconstructed from clean data (no 
noise) and noisy data are plotted together. When the 
anomaly volume was within the sensitive region of diffuse 
light ( anomaly central depth 10 mm), the largest discrepancy 
TABLE 3 
Computer simulation results in recovering an anomaly1 inside slab­
shaped and breast-shaped volume meshes 
Anomaly Anomaly Average 
central diameter Peak flow flow 
depth (mm)/ (mm)/ contrast/ contrast/ 
% error % error % error % error 
Slab-shaped 6.4/8.6% 7.2/28% 12.8-fold/28% 9.3-fold/7% 
Bread- 6.65/7% 7.5/25% 12.2-fold/23% 8.1-fold/19% 
shaped 
aA spherical anomaly with a diameter of 10 mm and 10-fold flow contrast was placed at 
7 mm beneath the surface of background issue volumes. 
Higher Reconstruction Accuracy Achieved in Simulations 
when the Anomaly was within the Sensitive Region of 
Diffuse Light 
The reconstruction results with varied anomaly locations 
and flow contrasts are presented in FIG. 24. The discrepan­
cies [FIG. 24(b)] between the reconstructed and assigned 
central locations of the anomaly were smaller than the mesh 
node distance (3 mm) at all depths. The reconstructed 
anomaly locations were more accurate in the sensitive 
region of diffuse light (errors 0.5 mm at central depths 10 
mm) compared to those in deeper depths.
between the reconstructed and assigned central locations of 
the anomaly was 1.2 mm [FIG. 25(b)], 0.8 mm greater than 
that (0.4 mm) without noise. Similarly, the largest recon-
35 struction errors in peak and average flow contrasts were 
33.2% and 31.0% larger than those reconstructed without 
noise [FIGS. 25(c) and 25(d)]. Apparently, adding noise 
reduced reconstruction accuracies in recovery of the 
anomaly. However, the major conclusions drawn herein are 
still valid. 40 
A Priori Knowledge of Anomaly Location and Volume 
Improved Flow Contrast Reconstruction in Simulations 
FIG. 26 demonstrates the improvements in the reconstruc­
tion of BFI contrasts using a priori knowledge of tumor 
45 location and volume in DCT image reconstruction. The top 
[FIGS. 26(a)-26(e)] and bottom [FIGS. 26(f)-26(j)] panels 
show the reconstructed results when the anomaly is at the 
central depth of 7 and 15 mm beneath the surface, respec­
tively. In each panel, image results without/with a priori 
50 information and without/with noise are plotted, respectively. 
The transect plots [FIGS. 26(e) and 26(j)] show the BFI 
distributions across the anomaly. The reconstruction accu­
racies in BFI contrasts were significantly improved when a 
priori knowledge of anomaly structural information was 
55 applied on data with and without noise. The peak/average 
BFI contrast errors were only 0.1 %/4% (without noise) and 
12.3%/12.3% (with noise), respectively, when using a priori 
structural information for the anomaly located in the sensi­
tivity region of diffuse light [i.e., at the central location of7 
Reconstruction errors in peak and average BFI contrast of
the anomaly at varied center location and assigned flow 
contrasts are displayed in FIG. 24(c ). The largest reconstruc­
tion errors in peak and average flow contrasts ranged from 
31.4% to -77.0% and -23.6% to -82.9% respectively, 
through all varied depths and flow contrasts. Similarly, the 
reconstructed peak and average BFI contrasts were more 
accurate in the sensitive region of diffuse light (peak and 
average BFI underestimations 27.8% and 45.3%, respec- 65
tively, at central depths 10 mm) compared to those in larger 
depths. 
60 mm, FIG. 26(e)]. The BFI contrast improvement at the 
deeper central depth of 15 mm was also remarkable [FIG. 
26(j)]. 
High Blood Flow Contrasts were Observed in Human 
Breast Tumors 
Two patients with low-grade carcinomas were imaged 
with our ncDCT system [FIGS. 27(b), 27(c), 27(e), and 
27(1)]. The first patient (Pl) was a 59-year-old female who 
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had ductal papilloma and low-grade adenocarcinoma in situ. 
According to the ultrasound imaging [FIG. 27(a)], the lesion 
with the dimension of 10.2x6.65 mm2 was located at 19.2 
mm beneath the skin surface. For the comparison of ultra­
sound and ncDCT results, the cross-section view of tumor 
flow contrast image through the ultrasound imaging plane 
(along the line of ultrasound transducer) and across the 
overlapped two ncDCT sources (Sl and S2) is presented in 
the reconstructed 3-D image [FIG. 29(b)]. The dimension of 
the reconstructed tumor by ncDCT with the FWHM thresh­
old was approximately 15.lx5.8 mm2 [FIG. 27(c)], which 
matched the ultrasound image [FIG. 29(a)]. However, the 
reconstructed tumor central location was 10.8 mm beneath 
ration of ncDCT was 30 mm, allowing for a penetration 
depth up to -15 mm. As such, it was not surprising that the 
reconstruction errors increased as the tumor center located at 
a depth deeper than 10 mm. The S-D separation (associated 
with light penetration depth) and SNR are two inter-related 
parameters that affect the utility of ncDCT. Future study 
should explore using source fibers with larger diameter to 
deliver greater light intensity for promoting the SNR and 
penetration depth. 
10 In contrast to the recovery of tumor location, the recon-
the breast surface, which differed from the ultrasound image 
result (19.2 mm). The peak and average tumor blood flow 15 
contrasts were 8.3-fold and 5.9-fold, respectively. Note that 
measurement noise caused some artifacts with µa'
0'a1(r, -i:)
lower than static µa(r, -i:) in the region bordering the recon­
structed tumor, leading to some negative flow values. 
The second patient (P2) was a 49-year-old female, who 20 
had an a-typical ductal hyperplasia and low-grade carcinoma 
in situ. Ultrasound images [FIG. 27(d)] show that the lesion 
centroid was located at 13.3 mm beneath the skin surface 
with the dimension of 8.5x3.5 mm2. Our ncDCT imaging 
results show a clear large tumor lesion with two small 25 
suspicious artificial anomalies [FIG. 27(e)]. The dimension 
of the reconstructed large tumor was approximately 12.3x 
5.1 mm2 [FIG. 27(1)] and its central depth was 12.4 mm 
beneath the breast surface, which fairly matched the ultra­
sound imaging result. The peak and average blood flow 30 
contrasts were 14.0-fold and 10.6-fold, respectively. Arti­
facts with negative flow values were also observed in the 
region bordering the reconstructed tumor. 
The in vivo imaging results are consistent with our 
computer simulation results (in that the tumor central loca- 35 
tion can be accurately recovered when the tumor locates 
within the sensitive region of diffuse light. 
Discussion and Conclusions 
struction of tumor blood flow contrasts was more compli­
cated. The reconstructed peak BFis were overestimated 
when the tumor located closer to the breast surface and 
underestimated when the tumor located out of the sensitive 
region of diffuse light [see FIG. 24(c)]. By contrast, the 
reconstructed average BFis were consistently underesti­
mated. These observations are similar to those in DOT for 
reconstruction of tumor absorption contrasts.44•45 It is 
known from the DOT practice that imaging sensitivity is 
higher at the shallow region beneath tissue surface.46 There-
fore, the reconstructed peak BFI from a single node close to 
the tissue surface tends to be overestimated. 
However, most of the reconstructed BFis from the tumor 
node are prone to be underestimated due to the nature of 
inverse problem. Since the number of boundary data (S-D 
pairs) in ncDCT is much smaller than the unknowns to be 
solved (i.e., BFis at all mesh nodes), the inverse problem is 
unstable,47 leading to the underestimation.44 In addition,
according to the definition of µatot
al(r, -i:)=µa(r)+µa d(r, -i:), BFI 
reconstruction errors come from both "static" and 
"dynamic" absorption coefficients. Therefore, dynamic flow 
contrast errors may be further enlarged by attributing all 
reconstruction errors of µatot
al(r, -i:) to dynamic µa d(r, -i:) 
while ignoring static errors of µjr). 
Similar to our previous findings,21 the relative changes of
tumor flow contrasts can be accurately reconstructed in a 
large range of flow contrast variations [see FIGS. 24(d) and 
24(e)]. The observed linear relationships with a slope of 
40 close to "1" indicate the ability of ncDCT to capture tumor 
blood flow changes, which can be potentially used to lon­
gitudinally monitor tumor hemodynamic responses to inter­
ventions. 
Since increased angiogenesis in breast tumor is com­
monly associated with blood flow increase, imaging of 
blood flow distribution in breast tissue is of great importance 
for tumor detection.8 The recently developed ncDCT in our
laboratory provides a unique imaging tool for noncontact 
detection of tumor blood flow contrasts.21 We have previ­
ously demonstrated the ability of ncDCT for imaging blood 45 
flow contrast in tissue phantoms with a simple semi-infinite 
geometry.21 The remaining challenge of applying ncDCT for
breast tumor imaging includes translating the FEM-based 
imaging algorithm to breast-shaped geometry and handling 
potential problems arising from the in vivo measurements. 50 
The goal of this study is to demonstrate the feasibility and 
evaluate the accuracy of ncDCT in detecting breast tumors. 
Computer simulations were used to investigate the origins 
of flow reconstruction discrepancies. From the simulations, 
As expected, adding noise reduced the reconstruction 
accuracies (see FIG. 25). However, tumors can still be 
reconstructed clearly from the boundary data with noise (see 
FIG. 25), indicating the feasibility of ncDCT for in vivo 
breast tumor detection. More importantly, adding a priori 
knowledge of the tumor volume and location improved 
significantly reconstruction accuracy (see FIG. 26), which 
agrees with previous observations in DOT.37•40•42 The
results from the two patients with low-grade carcinoma 
showed higher blood flow contrasts in the tumor regions 
compared to the surrounding tissues (see FIG. 27). The 
reconstructed positions of the two tumors on the x-y plane 
[see FIGS. 27(c) and 27(1)] agreed well with ultrasound 
imaging results [see FIGS. 27(a) and 27(d)]. The recon­
structed tumor central depth from the second patient (P2) 
also matched the ultrasound image. For the first patient (Pl), 
however, the reconstructed tumor central depth was at 10.8 
mm beneath the breast surface, which did not match the 
ultrasound finding (19.2 mm). This was likely due to deep 
location of the tumor (Pl), which was beyond the sensitive 
depth of diffuse light detected by our current system. To 
we observed similar reconstruction accuracies in blood flow 55 
contrasts and tumor central locations with slab-shaped and 
breast-shaped boundaries (see FIG. 23 and Table 3), indi­
cating the ability of ncDCT for reconstructing tumor flow 
contrast in human breast with irregular geometry. Further 
simulations on breast-shaped geometry evaluated recon- 60 
struction accuracies when tumors had different flow con­
trasts and located at different depths. The results suggested 
that the reconstructed tumor location and flow contrasts 
were more accurate when the tumor volume was within the 
sensitive region of diffuse light (see FIG. 24). Based on 
photon diffuse theory, the penetration depth of diffuse light 
65 confirm this, we conducted computer simulations with the 
same location of tumor and similar level of measurement 
noise, and we found that the reconstructed tumor located at is -1h of the S-D separation.35 038039 The largest S-D sepa-
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-8.5 mm beneath the breast surface (data are not shown).
The simulation result agrees well with our in vivo measure­
ment result.
48 
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In conclusion, this reports the first flow image reconstruc­
tion results in human breast tumors using a novel ncDCT 30 
system. Results from computer simulations suggest that 
relatively high accuracy can be achieved when the entire 
tumor was within the sensitive region of diffuse light. Image 
reconstruction with a priori knowledge of the tumor volume 
and location can significantly improve the accuracy in 35 
recovery of tumor blood flow contrasts. In vivo imaging 
results from the two breast carcinomas show higher blood 
flow contrasts in the tumor regions compared to the sur­
rounding tissues, which are comparable with previous find­
ings. The noncontact design of the ncDCT system has the 40 
potential to be used for imaging blood flow distributions in 
soft and vulnerable tissues without distorting tissue hemo­
dynamics. 
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Ex. 5: Speckle Contrast Diffuse Correlation 
Tomography of Complex Turbid Medium Flow 
Near-infrared (NIR) light enables the deep tissue inves­
tigation of microvascular hemodynamics.1•2 Blood flow is
one such available observable promoting a wealth of physi­
ological insight both individually and in combination with 
other metrics. Diffuse correlation spectroscopy (DCS) and, 
to a lesser extent, tomography (DCT) have received interest 
over the past two decades as noninvasive methods for blood 
flow recovery.3•4 In typical DCS implementations, the tem­
poral fluctuations in individual speckles are measured by 
avalanche photodiodes (APDs) coupled to independent opti­
cal fibers. 
These impose a physical and monetary overhead limiting 
the potential sampling density and temporal resolution. In 
our previous work, we extended DCS into a noncontact 
lens-based system succeeded by noncontact DCT (ncDCT) 
within a finite element method (FEM) framework. 1 •5 These
studies provided desirable operational attributes, especially 
the elimination of hemodynamic alterations due to contact 
compression and the ability to incorporate arbitrary tissue 
boundaries and compositions. Moreover, our FEM recon­
struction method is based on readily available open source 
software for seamless integration of geometries and inver­
sion algorithm techniques. 6 The mechanical scanning of an 
optical fiber array in ncDCT to cover a region of interest 
(ROI) provides one solution to increasing sampling density 
and reducing cost, but increases measurement duration and 
may introduce motion artifacts. Another solution we outline 
here, recruitment of charge-coupled device (CCD) detection, 
promotes advantages including increased sampling density, 
decreased sampling times and equipment overhead, and 
geometry extraction potential. CCD detection has frequently 
been utilized successfully in other flow monitoring tech­
niques such as laser speckle contrast imaging.7 This modal­
ity applies a wide-field illuminating source to enable rapid 
collection of two-dimensional images depicting spatial ves­
sel flow variations on superficial tissues. There have been a 
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few recent advancements toward blood flow monitoring in 
deep tissue with NIR point-source illumination and CCD 
detection. Diffuse speckle contrast analysis and speckle 
contrast optical spectroscopy approach the problem by using 
the relationship between a speckle contrast parameter and 
DCS theory.8'9 Speckle contrast optical tomography (SCOT)
extends the concept using an analytical Born approximation 
in the inverse problem on transmission based measurement 
50 
Tikhonov regularization with minimization with respect to 
optical properties and a biconjugate gradient stabilized itera­
tive inversion scheme for Jacobian construction, as imple­
mented in NIRFAST. The BFis are then extracted from the 
reconstructed combined absorption coefficient using its defi­
nition above. 
The speckle contrast with shot and dark correction were 
performed as discussed herein. 
For physical experimentation, a liquid phantom provided 
a homogeneous tissue-like model by a mixture of distilled 
water, India ink (Black India, MA), and Intralipid (Fresenius 
Kabi, Sweden).15 The property of real tissue was mimicked 
by setting µa=0.05 cm-1, µ's=7.0 cm-1, and DB=lxl0-
8 
cm2/s (assumed15). A cube-shaped solid phantom (µa =0.05 
of parallel-plane tissue phantoms.10 We move forward from 
these studies in the direction of reflectance tomographic 10 
imaging by developing a robust technique combining the 
benefits of CCD detection and our FEM based DCT flow 
reconstruction. In contrast to SCOT which formulates the 
inverse problem with a direct analytical relationship 
between the speckle contrast and mean-square displacement 
of moving scatterers, we simplify the process by converting 
the speckle contrast to boundary flow indices and retaining 
our leverage of FEM-based DOT reconstruction advance­
ments. Specifically, in this study we are able to take advan­
tage of the nonlinear iterative algorithms, finite-element 20 
support functions, data filtering, and the many features 
included in the modified NIRFAST for DCT.5 This is due to 
the formal similarity between DOT and DCT as outlined in 
our previous publication.5 This unique method, termed 
speckle contrast DCT (scDCT), facilitates three-dimensional 
(3D) reflectance flow contrast imaging of complex turbid 
media. As this technique promotes incorporation of both 
heterogeneous optical properties and arbitrary tissue bound­
aries, scDCT can utilize highly representative sample char­
acteristics in the recovery of accurate flow data. We apply 30 
this scDCT technique on a reflectance-based measurement 
which more adequately represents the situation encountered 
15 cm-1, µ15=7.0 cm-1, and aDB, was measured by DCS to be
about three orders of magnitude lower than the liquid
background) of carbon black, titanium dioxide, silicone with
7 mm side length was submerged to a 2 mm depth beneath
the surface of the FOY center.
in larger subjects such as humans where transmission is not 
practical in most cases ( due to the limited penetration depth 
Results and Discussion 
During both heterogeneity presence and absence experi­
ments, the scDCT measurement protocol consisted of 
speckle contrast recovery over the liquid surface in a 
sequential manner for each of the four sources. For each 
25 source, 30 frames were acquired with an exposure time of 2 
ms and frame rate of 8 frames/s. We defined 9x9 detectors 
centered in the FOY over 1.0xl.O cm [FIG. S(b)] surround­
ing the target surface. The resulting S-D separations were all 
1.0-2.0 cm with 1.25 mm distance between detectors. Each 
detector (0.42x0.42 mm) included 3x3 windows and each 
window contained 7x7 pixels (8 µm pixel size). Measured 
speckle contrast was calculated per window and averaged 
across those corresponding to their associated detector. 
of light), enhancing translatability. A smear correction alga- 35 
rithm is also incorporated in this study to resolve the 
influences on data uniquely incurred when using frame­
transfer CCDs with the point-source illumination and reflec­
tance setup. 
Localized speckle contrast averages were then calculated 
along obtained frames. The homogeneous phantom was 
measured with scDCT first in the manner just described, 
followed by a standard DCS measurement for calibration 
purposes. Practically, the optical constant � is not available 
for measurement. A calibration factor was thus determined 
Methods and Materials 
As shown in FIG. S(a), the scDCT equipment and experi­
mental setup involve a 785 nm long coherence laser ( coher­
ence length>5 m, CrystaLaser, NV) to emit photons into the 
sample. A fiber optic switch (VX500, Dicon, CA) with 
fourchannel outputs delivered photons to four multimode 
optical fibers (FT200UMT, Thorlabs, NJ) individually. The 
fibers [Sl-S4 in FIG. S(b)] were located 1.5 cm from the 
field of view (FOY) edge centers. An electron-multiplying 
CCD (EMCCD; Cascade lK, Photometrics, AZ) with a 
zoom lens (Zoom 7000, Navitar, N.Y.) aligned concentri­
cally to the FOY detected the speckle patterns due to the 
diffused light. The focal length of the image lens was 35 mm, 
making the focal plane on the surface of the liquid phantom. 
An F number of 8 was chosen to ensure the speckle size 
satisfied the Nyquist sampling criteria.11 
The application of DCS theory was applied as discussed 
herein. Reconstructions of the combined term, µa(r)+µa d(r, 
40 which equals to the ratio between speckle contrasts from 
scDCT and those calculated using Eq. (2) with the semi­
infinite CDE analytical solution for gl along with DCS 
(�=0.5) measured BFI on the homogeneous phantom. 
FIG. 28(a) illustrates the intensity distribution with source 
45 S2 on the homogeneous phantom. FIG. 28(b) shows the 
distribution after desmearing, demonstrating a normal pre­
sentation for point-source intensity. To quantify the des­
mearing influence, we consider an array of detectors defined 
along the center row in line with the source location as 
50 shown relative to S2 in FIG. 28(a). The S-D ranges from 1.0 
to 2.0 cm. For each remaining source the detectors are 
defined similarly, but with different orientation based on the 
source location. The measured K for such detectors and each 
source with and without desmearing is shown in FIG. 29(a), 
55 along with the calculated K. To refine this depiction, we 
increased effective detectors along the center row to 21 [see 
the ROI and dots in FIG. 29(a)] while defining them the 
same way as done elsewhere in the experimentation. -i:), are then carried out in NIRFAST using the "Standard" 
options for a single wavelength and continuous-wave appli­
cation. A median filter built into NIRFAST is used for 60 
It can be seen that the desmeared K correlates with the 
calculation. The region of usable speckle contrast without 
desmearing is obviously limited with S2 most noticeably 
impacted. This is due to our system configuration in which 
frame transfer occurs in the direction from S2 to S4. The DB 
value across the center row of detectors is shown in FIG. 
phantom test reconstructions as it assists in stabilizing 
inherent experimental noise. This is because in real mea­
surements the inverse problem is likely to generate odd 
solutions in a few nodes which may not be encountered with 
ideal simulation.5'6 The median filter offers six-level 
smoothing from none to high (0-5) and we select level 2 in 
this study. The inverse problem is set up using modified-
65 29(b). The DB value achieved from DCS at 2.0 cm S-D 
separation was 1.28xl0-8 cm2/s. The independently aver­
aged DB for Sl-S4 at the 21 detectors were (1.19±0.05)x 
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10-s cm2/s, (1.18±0.08)x10-8 cm2/s, (1.17±0.06)x10-8 cm2/ 
s, and (1.13±0.06)x10-8 cm2/s. These are in good agreement
(within 12%) with the standard DCS measurement. The 
comparison of K distributions measured from Sl on the 
homogeneous and heterogeneous phantoms is shown in FIG. 5 
30. 
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Further difficulties may be encountered when extending 
scDCT to real complex media. For example, surface curva­
ture may result in modified light distributions and S-D 
separations potentially reducing the accuracy and reliability 
of reconstructed flow contrasts. These issues are beyond the 
scope of the current paper, but can be addressed in the future 
through computer simulations, possible free-space correc­
tions,17 and telecentric zoom lens incorporation.18•19 
Conclusions 
We reported a cost-effective CCD-based reflectance 3D 
flow imaging system from laser speckle contrast with four 
target-contacted fibers serving as point sources. Beyond 
dark and shot noise corrections, we successfully incorpo­
rated an additional desmearing algorithm. This correction 
Next, we measured speckle contrast in the phantom with 
heterogeneity. The corresponding boundary BFis were com­
bined with the BFI obtained from the homogeneous phan­
tom measurements for image reconstructions. We used a 10 
finite element mesh [dimension(mm): 60(H)x60(W)x30(D)] 
centered at (0,0,15) with a 3 mm node distance.5 The mesh
was refined in the known region of heterogeneity to improve 
detection resolution while not overwhelmingly increasing 
the number of nodes. Refinement was within a 15 mm radius 15 was found to be imperative for reflectance applications using 
a point source to obtain accurate deep tissue speckle con­
trast. 
( e.g., inclusive of five elements) centered from (0,0,30) to a 
1.5 mm node distance (total nodes: 10 307) using ANSYSR 
(ANSYS, PA). The relative blood flow, rBF, is used to 
denote the ratio of phantom with heterogeneity to homoge­
neous phantom aDB's. As presented in our previous work,
5 
20 
the algorithm based on an open software package NIR­
FAST6 was used to reconstruct rBF in 3D. The reconstructed
image from homogeneous phantom and heterogeneous 
phantom is shown in FIGS. 3l(a) and 31(b). A reconstructed 
heterogeneity was clearly recognizable from the overlaid 
cross-sections compared between the two images. FIG. 
3l(c) shows cross sectional views of the heterogeneity 
extracted by half max contrast threshold criteria. The aver­
aged heterogeneity rBF was 0.38 with center (0.0, -0.1, 
25.0) close to the actual center (0, 0, 24.5). Reconstructed 
heterogeneity side length was 7 .2 mm with dimensions that 
were accurate compared to the true solid phantom. We 
likewise simulated the phantom experiment by computer 
using identical parameters. The region with heterogeneity 
extracted by half max contrast threshold is shown in FIG. 
31(d). The reconstructed heterogeneity averaged rBF was 
0.37 with center (-0.1, 0.0, 24.0), similar to phantom results 
(averaged rBF within 3% of phantom test results). Corre­
sponding 3D flow distributions were also similar to the 
phantom experiment [FIG. 31(b)] and hence are not shown. 
We also performed two simulations with off-center loca­
tions, but otherwise similar setup, of the heterogeneity and 
found the reconstructed center and side length in agreement 
with the expectation. 
Flow contrast was extracted using the relationship 
between a correlation diffusion equation solution and the 
speckle contrast. A FEM-based DCT framework was 
employed to reconstruct spatially distributed blood flow. 
This system was validated using a reflectance-based mea­
surement on a liquid phantom with an internally placed 
heterogeneity. Compared to our previous ncDCT design, 5 
25 this system demonstrated potential for fast and dense bound­
ary data acquisition and deep tissue hemodynamics tomog­
raphy translating directly to human studies ( e.g., burn/ 
ulcerous tissue flow detection). 
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In this study, an exposure time of 2 ms was selected to 
achieve a good contrast to noise ratio.16 The reconstruction
and boundary data parameters of delay time t and window 
size used herein have been discussed in detail elsewhere.5•11 
We acknowledge that static scatterer contributions can 
degrade the current model. Ideally, recovered rBF would be 50 
zero. However, we only sought to validate 3D flow contrast 
detection using our new scDCT method rather than optimize 
flow recovery accuracy, and we produced sufficient contrast 
to identify and characterize the anomalous presence. The 
agreement between scDCT and DCS on a homogeneous 55 
phantom and between simulation and phantom in heteroge­
neity detection supports success. Furthermore, multiple two­
dimensional S-D pairs provided by the CCD omit the probe 
scanning in ncDCT,5 and thus significantly improve the
spatial and temporal resolution. In addition, due to decreas- 60 
ing signal with increased S-D separation using a point 
source we were limited to at most 2.2 cm after noise 
correction. Nevertheless, this S-D separation is still capable 
of probing tissues -1 cm depth. We also note that although 
the FEM framework allows incorporating complex hetero- 65 
geneities and boundaries, we chose to exemplify our tech­
nique in a straightforward setup. 
Ex. 6: nc_scDCT Test in Tissue Phantom and 
Human Forearm 
The fully noncontact speckle contrast diffuse correlation 
tomography nc_scDCT system integrated with a crossed 
pair of polarizers (FIG. 32(a)) was tested in the homogenous 
tissue phantom with source and detectors pattern in FIG. 
32(b). FIG. 32(c) suggests the reflectance nc_scDCT can 
produce homogenous flow index in homogenous phantom. 
The spectroscopic version of nc_scDCT system has been 
tested on a human forearm. Protocol included 3-minute 
baseline, 4-minute arterial occlusion and 3-minute recovery. 
Flow index of each point were normalized to the mean value 
of the baseline. FIG. 33(a) shows the experimental setup. 
FIG. 33(b) shows the relative blood flow (rBF) of four S-D 
distances (3 mm, 6 mm, 10 mm, 14 mm). 
The nc_scDCT system integrated with Galva mirror was 
tested on liquid tissue phantom. FIG. 34(a) shows the 
pattern of sources and detectors; 16 sources and 361 detec­
tors were evenly distributed in an ROI of 3.6 cm2. A
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pump-connected 6 mm diameter cylindrical tube anomaly 
was filled with liquid and small pieces of solid phantom, and 
was placed 2 mm beneath the liquid surface. The pump 
speed was set as 60 ml/min. The CCD camera captures 
image at each source position at 10 ms exposure time. FIG. 
34b shows the reconstructed heterogeneity anomaly, which 
agrees with the setup. To the best of our knowledge, this is 
the first 3-D flow image generated by a reflectance 
nc_scDCT. 
The foregoing has been presented for purposes of illus­
tration and description. It is not intended to be exhaustive or 
to limit the embodiments to the precise form disclosed. 
Obvious modifications and variations are possible in light of 
the above teachings. All such modifications and variations 
are within the scope of the appended claims when inter­
preted in accordance with the breadth to which they are 
fairly, legally and equitably entitled. All documents refer­
enced herein including patents, patent applications and 
journal articles and hereby incorporated by reference in their 
entirety. 
We claim: 
1. An optical method for three-dimensional (3-D) reflec­
tance imaging of blood flow distribution in deep tissue ofup 
to about 1.5 cm with an arbitrary tissue geometry compris­
ing: 
projecting/focusing an imaging probe comprising long­
coherence laser sources and a detector array on a tissue 
surface of a subject; 
applying source beams of near-infrared light to the tissue 
through a set of optical lenses; 
detecting diffused near-infrared light reflected from the 
tissue surface through a second set of optical lenses by 
a detector array and 
constructing a 3-D image based on a data set comprising 
measured diffused near-infrared light from the detector 
array, 
wherein the sources and the detector array are not in 
physical contact with the tissue. 
2. The method of claim 1, wherein the detector array
comprises a one-dimensional (1-D) array of avalanche pho­
todiodes. 
54 
3. The method of claim 1, wherein the detector array
comprises a two-dimensional (2-D) array of avalanche pho­
todiodes. 
4. The method of claim 1, wherein the imaging probe is
affixed to a motorized stage such that the probe can be 
systematically and automatically moved across a region of 
interest of the tissue. 
5. The method of claim 1, wherein the probe is focused
through a wound, surgical opening, or a tissue flap within the 
10 subject. 
6. The method of claim 1, wherein the 3-D image is
reconstructed through a system that applies a finite-element­
method from the measured data set. 
7. An optical method for 3-D imaging of blood flow
15 distribution in deep tissue of up to approximately 1.5 cm 
with an arbitrary tissue geometry comprising: 
applying near-infrared light through source fibers to bor­
ders of a region of interest of a tissue of a subject; 
detecting the near-infrared diffused light through an opti-
20 cal lens coupled to a charge-coupled-device (CCD),
wherein adjustable optical zoom lenses provide a focal 
length and varied field of view such that the region of 
interest is covered by the 2-D array of detectors pro­
vided by the CCD; and, 
25 constructing an image based on a data set comprising
measured diffused near-infrared light from the 2-D 
array of detectors provided by the CCD. 
8. The method of claim 7, wherein the source fibers are
not in contact with the subject and further wherein the source 
30 fibers are projected onto tissue surface using adjustable 
optical zoom lenses. 
9. The method of claim 8, wherein the near infrared light
is projected to the tissue by redirection using a Galva mirror. 
10. The method of claim 7, wherein the charge-coupled-
35 device along with the sources is connected to a motorized 
stage such that the probe can be systematically moved across 
a region of interest of the tissue. 
11. The method of claim 7, wherein the image is con­
structed through a system that applies a finite-element-
40 method from the measured data set. 
* * * * *
